68 results on '"Y, Lecluse"'
Search Results
2. Herpes Simplex Virus Infection Mimicking Bullous Disease in an Immunocompromised Patient
- Author
-
Carla A F M Bruijnzeel-Koomen and Anne L Y Lecluse
- Subjects
medicine.medical_specialty ,medicine.drug_class ,medicine.medical_treatment ,viruses ,Published: June 2010 ,Dermatology ,Herpes simplex virus ,medicine.disease_cause ,Tzanck test ,medicine ,lcsh:Dermatology ,business.industry ,Pemphigus vulgaris ,Immunosuppression ,lcsh:RL1-803 ,medicine.disease ,Herpes simplex infection ,Immunology ,Corticosteroid ,Histopathology ,Bullous pemphigoid ,Differential diagnosis ,business - Abstract
Immunodeficient patients are at risk of developing extended or atypical herpes simplex virus infections, which can be easily misdiagnosed. We present the case of a 79-year-old, treatment-induced (oral corticosteroid), immunocompromised female with an extensive atypical herpes simplex virus infection. This patient presented with multiple erosions and vesicles on the trunk with a subacute onset. The clinical differential diagnosis was herpes simplex infection, herpes zoster infection, pemphigus vulgaris or bullous pemphigoid. Due to the atypical clinical presentation and negative Tzanck test, suspicion of viral infection was low. High-dose steroid treatment was initiated. Subsequent histopathology, however, showed a herpes simplex virus infection. After discontinuing steroid treatment and initiating antiviral treatment, the patient recovered within a week. Emphasis must be placed on the importance of clinical awareness of extended and clinically atypical herpes simplex infections in immunocompromised patients. A negative Tzanck test does not rule out the possibility of a herpes infection.
- Published
- 2010
3. Erythropoietic protoporphyria without skin symptoms-you do not always see what they feel
- Author
-
Suzanne G.M.A. Pasmans, Vigfus Sigurdsson, Huib van Weelden, Veronica C. M. Kuck-Koot, I M B Russel, Jorge Frank, Anne L. Y. Lecluse, and University of Groningen
- Subjects
EXPRESSION ,medicine.medical_specialty ,Protoporphyria, Erythropoietic ,Short Report ,Protoporphyrins ,Porphyrin metabolism ,Skin Diseases ,Diagnosis, Differential ,chemistry.chemical_compound ,Porphyrias ,CHILD ,Photosensitivity ,medicine ,Humans ,Pediatrics, Perinatology, and Child Health ,Photosensitivity Disorders ,Nose ,PROTOPORHYRIA ,Erythropoietic protoporphyria ,integumentary system ,business.industry ,medicine.disease ,Skin symptoms ,Dermatology ,Pathophysiology ,Surgery ,medicine.anatomical_structure ,Porphyria ,chemistry ,Child, Preschool ,CELLS ,Pediatrics, Perinatology and Child Health ,Protoporphyrin ,Female ,Differential diagnosis ,business ,Ferrochelatase - Abstract
Erythropoietic protoporphyria (EPP) is an inherited disorder of the porphyrin metabolism that often remains undiagnosed in children. We report on a 4-year-old girl who had been suffering for 1 year from recurrent painful crises affecting her hands, feet, and nose following sun exposure. Objective skin lesions were absent until the age of 6. Porphyrin analysis revealed elevated free erythrocyte protoporphyrin (FEP) levels confirming the diagnosis of EPP. This illustrates that skin lesions might be completely absent in children affected with EPP, a fact that has only been reported once previously. Because EPP can manifest with few and unspecific cutaneous symptoms or no skin lesions at all, like in this patient, the diagnosis of EPP might be delayed or missed. EPP should be excluded in all photosensitive children, especially when discomfort is disproportionate to the extent of the cutaneous lesions. The clinic, pathophysiology, diagnosis, complications, and therapy of EPP are discussed.
- Published
- 2007
4. Receding Horizon Adaptive Optimal Nonlinear Control: An Experimental Evaluation
- Author
-
Z. Lakhdari, D. Atroune, Y. Lecluse, and J. Provost
- Subjects
Mathematical optimization ,Nonlinear system ,Adaptive control ,Discrete time and continuous time ,Control theory ,Computer science ,Trajectory ,Linear model ,Nonlinear control ,Optimal control - Abstract
This paper presents an application of Receding Horizon Adaptive Optimal Nonlinear Control (RHAONC) to the tracking thermal trajectory of a cryogenic system. In order to take into account the nonlinearities of this plant, a nonlinear delayed discrete time model is used. Comparison with adaptive optimal controller using linear model is made to show the improvement of performances obtained by making use of the nonlinear scheme
- Published
- 1995
- Full Text
- View/download PDF
5. Partial State Model Reference Control of an Industrial Oven
- Author
-
G. Villeneuve, Y. Lecluse, P Dorléans, and M. Barrat
- Subjects
State model ,Engineering ,Control and Systems Engineering ,Control theory ,business.industry ,Mechanical Engineering ,Control (management) ,Control signal ,Control engineering ,Tracking (particle physics) ,business - Abstract
The partial-state model/reference adaptive controller of Irving et al. and M' Saad is applied to an industrial oven The performances are compared with those of a GPC algorithm. The tracking ability is quite as good, and the control signal is smoother.
- Published
- 1992
- Full Text
- View/download PDF
6. Control Algorithm for Microwave Sintering in a Resonant System
- Author
-
M. Alliouat, J. Massieu, L. Mazo, and Y. Lecluse
- Subjects
Materials science ,Control algorithm ,business.industry ,Metals and Alloys ,Sintering ,Dielectric ,Condensed Matter Physics ,Sample (graphics) ,Electronic, Optical and Magnetic Materials ,Computer control ,Condensed Matter::Superconductivity ,Microwave heating ,Absorbed power ,Microwave sintering ,Ceramics and Composites ,Optoelectronics ,Electrical and Electronic Engineering ,business - Abstract
This paper describes a computer control method for sintering dielectric materials by microwave heating. The algorithm used allows control of either the surface temperature of the sample or the absorbed power. The experimental results compare favorably with those of classical sintering methods.
- Published
- 1990
- Full Text
- View/download PDF
7. Decreased coenzyme Q10 concentration in plasma of children with cystic fibrosis
- Author
-
Johan Van Der Laag, Robin van den Berg, Anne L. Y. Lecluse, Johanna H. Oudshoorn, Wouter H. J. Vaes, and Roderick H. J. Houwen
- Subjects
Male ,medicine.medical_specialty ,Pancreatic disease ,Malabsorption ,Adolescent ,Cystic Fibrosis ,Ubiquinone ,Coenzymes ,Cystic fibrosis ,chemistry.chemical_compound ,Internal medicine ,Blood plasma ,medicine ,Humans ,Child ,Chromatography, High Pressure Liquid ,Coenzyme Q10 ,Lung ,business.industry ,Cholesterol ,Gastroenterology ,medicine.disease ,Fat malabsorption ,Endocrinology ,medicine.anatomical_structure ,chemistry ,Pediatrics, Perinatology and Child Health ,Female ,business ,Oxidation-Reduction - Abstract
OBJECTIVES: Coenzyme Q10 (CoQ10) is an effective lipophilic antioxidant and protects against lipid peroxidation by scavenging radicals. Patients with cystic fibrosis generally have fat malabsorption; thus, we hypothesized that overall plasma CoQ10 concentration in pediatric patients with cystic fibrosis might be diminished. Because these patients have increased oxidative stress due to chronic pulmonary inflammation, we also assumed that the oxidized form of CoQ10 might be relatively increased. PATIENTS AND METHODS: The total plasma CoQ10 levels and the oxidized and reduced form were measured by high-performance liquid chromatography in 30 children with cystic fibrosis (mean FEV1 % predicted = 88.5% ± 18.7%) and 30 age-matched controls. RESULTS: Total plasma CoQ10 levels were significantly lower in the cystic fibrosis group as compared with the control group (0.87 ± 0.42 μmol/L and 1.35 ± 0.39 μmol/L, respectively; P < 0.001). When correcting for the lower serum cholesterol level in patients with cystic fibrosis, this difference remained significant: the CoQ10/cholesterol ratio (μmol/mol) was 268.8 ± 136.7 and 334.0 ± 102.9 in patients and controls, respectively (P < 0.05). However, the CoQ10 redox status was identical in patients and controls (86.4% ± 7.1% and 85.4% ± 7.3%, respectively). CONCLUSIONS: We found that the overall plasma CoQ10 concentration is lower in patients with cystic fibrosis, probably because of fat malabsorption. The CoQ10 redox status was not disturbed, indicating that CoQ10 could still be adequately regenerated in this group of patients with cystic fibrosis with mild-to-moderate pulmonary disease. © 2006 Lippincott Williams & Wilkins, Inc.
- Published
- 2006
8. Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents
- Author
-
S Dutoit, Y Lecluse, A. Jaffre, Lebailly P, P Gauduchon, I Baldi, Jean Breton, A. Vital, H. Loiseau, F Chapon, and V Loyant
- Subjects
Male ,Health, Toxicology and Mutagenesis ,DNA Mutational Analysis ,Biology ,Toxicology ,medicine.disease_cause ,Nucleic Acid Denaturation ,Denaturing high performance liquid chromatography ,chemistry.chemical_compound ,Occupational Exposure ,Genetics ,medicine ,Humans ,Pesticides ,Genetics (clinical) ,Carcinogen ,Chromatography, High Pressure Liquid ,Mutation ,Brain Neoplasms ,DNA, Neoplasm ,Exons ,Pesticide ,chemistry ,Case-Control Studies ,Etiology ,Cancer research ,Solvents ,Immunohistochemistry ,Female ,Occupational exposure ,Solvent exposure ,Tumor Suppressor Protein p53 ,Mutagens - Abstract
The aetiology of brain tumours remains unclear. Occupational exposures to pesticides and organic solvents are suspected risk factors. The case-control study CEREPHY (221 cases, 442 controls) carried in the Departement de la Gironde in France revealed a significantly increased risk of brain tumours for subjects most exposed to pesticides. In some cancers, TP53 mutations could reflect exposure to specific carcinogens. These mutations are present in approximately 30% of astrocytic brain tumours. In a pilot study, we explored the hypothesis that pesticide or solvent exposure could raise the frequency of TP53 mutations in brain tumour cells. We investigated TP53 mutations in exons 2-11 by denaturing high performance liquid chromatography (DHPLC) and sequencing, and p53 accumulation by immunohistochemistry in brain tumour of the 30 patients from CEREPHY study with a history of occupational exposure to pesticides (n = 21) and/or organic solvents (n = 14) for whom tumoral tissue was available. Included cases concerned 27% of CEREPHY cases exposed to pesticides and, based on the cumulative index of occupational exposure, they were more exposed to pesticides. There were 12 gliomas, 6 meningiomas, 7 neurinomas, 2 central nervous system lymphomas and 3 tumours of other histological types. We detected TP53 mutations in three tumours, which is similar to the expected number (3.3) calculated from 46 published studies referenced in the IARC TP53 mutations database, taking into account histological types. Considering TP53 mutations previously detected in the laboratory by DHPLC and the frequency of TP53 polymorphisms detected in this sample (similar to published data), the TP53 mutations rate is probably not underestimated. These preliminary results, even if it was on a limited number of tumours, are not in favour of the role of pesticide or organic solvent exposure in the occurrence of TP53 mutations in brain tumours.
- Published
- 2005
9. Agriculture 2
- Author
-
L. E. B. Freeman, A. Blair, E. Q. Ahonen, V. Porthe, F. G. Benavides, J. Benach, R. Hazarika, I. Baldi, P. Lebailly, M. Barrau, V. Bouchart, Y. Lecluse, A. Garrigou, Y. C. Chang, J. L. Lu, N. Schmeisser, B. Mester, W. Ahrens, E. Niez, N. Leveque, C. Meyer, and A. Commitee
- Subjects
Public Health, Environmental and Occupational Health - Published
- 2007
- Full Text
- View/download PDF
10. Erratum: Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation
- Author
-
A Hamaï, C Richon, F Meslin, F Faure, A Kauffmann, Y Lecluse, A Jalil, L Larue, M F Avril, S Chouaib, and M Mehrpour
- Subjects
Cancer Research ,Genetics ,Molecular Biology - Published
- 2007
- Full Text
- View/download PDF
11. Détermination des structures hyperfines des niveaux de triplet de la configuration 5 s 5 d des isotopes 111Cd et 113 Cd
- Author
-
Y. Lecluse and M. Chantepie
- Subjects
Physics ,Nickel compounds ,Zinc compounds ,Physical chemistry ,Cobalt compounds - Abstract
Nous avons mesure les positions des croisements de niveaux dans les etats de triplet de la configuration 5 s 5 d des isotopes 111Cd et 113Cd en utilisant un mode d'excitation par echelons. Nous avons determine les valeurs des rapports (A/g)111 et (A/g)113 .
- Published
- 1971
- Full Text
- View/download PDF
12. [Immunohistochemical identification of olfactory esthesioneuromas. Apropos of 16 cases]
- Author
-
D, Vitrey, A, Boddaert, and Y, Lecluse
- Subjects
Antibodies, Neoplasm ,Nose Neoplasms ,S100 Proteins ,Antibodies, Monoclonal ,Prognosis ,Neoplasm Proteins ,Olfactory Mucosa ,Phosphopyruvate Hydratase ,Glial Fibrillary Acidic Protein ,Immunologic Techniques ,Humans ,Keratins ,Neuroectodermal Tumors, Primitive, Peripheral ,Schwann Cells ,Nasal Cavity - Abstract
We report anatomoclinical and immunohistochemical analysis of sixteen cases of esthesioneuroblastomas. Microscopic study confirm difficulty of diagnostic for this tumors. Results of S 100 protein reaction for Schwann cells identification, NSE and HNK1 reaction for nervous cells and KL1 reaction for epithelial cells drawn from olfactory mucosa, allow definition of immunologic ENO profile. Pattern immunologic criteria are defined by S 100, NSE or/and HNK1, and eventually KL1 positive reactions permit differential diagnosis with other nervous tumors or undifferentiated carcinomas of nasal fossa. Histo-prognostic patterns are defined by S 100 reactivity distributed in neoplastic cells and cytoplasmic process of cells, to form a continuous network in well differentiated ENO and discontinuous network in undifferentiated forms of ENBO. These results confirm histogenesis of this tumor derived from olfactory mucosa and emphasized only two distinct types: neuro epithelial tumors corresponding to ENEO and cases of ENBO and nervous tumors grouping ENCO and any cases of ENBO.
- Published
- 1987
13. [Fibroadenoma of the breast with atypical clear-cell epithelial hyperplasia. Apropos of 7 cases. Immunohistochemical study]
- Author
-
M J, Lacombe, A, Llombart-Bosch, Y, Lecluse, F, Bertin, and G, Contesso
- Subjects
Adult ,Immunoenzyme Techniques ,Hyperplasia ,Time Factors ,Humans ,Breast Neoplasms ,Female ,Breast ,Adenofibroma ,Follow-Up Studies - Abstract
We report 7 cases of unusual fibroadenomas of the breast. They are characterized by an exuberant cellular proliferation within the ductal lumens. They appear in young women from 20 to 40 years old. These lesions are histologically identical to those described by Azzopardi (1979) under the name of "Argyrophilic cells in fibroadenomas" and by Eusebi and Azzopardi (1980) and by Govoni (1981) and called "Lobular endocrine neoplasia in fibroadenoma of the Breast". An immunohistochemical study reveals a major positivity of these cells, in all cases, with Antikeratin Antibody (anti Kl1) and with Epithelial Membrane Antigen (anti EMA) proving the epithelial origin of these cells. There cells cannot yet be regarded as belonging to the neuro-endocrine group, because of the negativity, in all cases of Grimelius and Bodian stains, and of the very heterogeneous positivity observed with Neuron-Specific Enolase antibody (anti NSE) and with anti Human Natural Killer antibody (anti HNK). These cellular proliferations seem to us, on the microscopical point of view related to the atypical epithelial hyperplasias of the breast, and different from the in situ lobular carcinoma. Thus we propose to call these lesions "variant of the breast fibroadenoma" characterized by an atypical epithelial clear cell hyperplasia. The treatment of these lesions merely consists of a lumpectomy. Only one case is associated with an eleven years free of disease follow-up: a follow-up comprised between on to fifteen months is observed in the others cases. The knowledge of these benign lesions appears to us very important, to avoid improper treatment caused by an erroneous diagnosis of carcinoma developing in a breast fibroadenoma.
- Published
- 1986
14. TET2-mediated 5-hydroxymethylcytosine induces genetic instability and mutagenesis
- Author
-
Lise Secardin, William Vainchenker, Olivier Bernard, Alexander A. Ishchenko, Murat Saparbaev, Emna Mahfoudhi, Philippe Rameau, Véronique Della Valle, Ibtissam Talhaoui, Isabelle Plo, Xenia Cabagnols, Salem Abbes, Hématopoïèse normale et pathologique (UMR 1170 ), Université Paris-Sud - Paris 11 (UP11) - Institut Gustave Roussy (IGR) - Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire d'hématologie moléculaire et cellulaire, institut Pasteur de Tunis, Institut Pasteur de Tunis - Réseau International des Instituts Pasteur, Institut Gustave Roussy (IGR), Réparation de l’ADN (CNRS UMR 8200), This work was supported by grants from Agence Nationale de la Recherche (ANR-Blanc 2013 GERMPN) to IP and [ANR Blanc 2010 Project ANR-10-BLAN-1617] to IP and MS, Association pour la Recherche contre le Cancer (ARC) (ARC libre 2012) to IP, Electricité de France (http://www.edf.fr) RB 2014-26 to MS and Fondation de France (http://www.fondationdefrance.org) [#2012 00029161] to AAI. Labex GR-Ex (IP, WV) is funded by the program 'Investissements d’avenir'. EM was funded by INSERM/DGRST then a grant from Institut Pasteur from Tunis, Tunisia. LS were supported by Ph.D grants from the Cancéropôle Région Ile de France (DIM cellule souche). XC was supported by Ph.D MENRT grant. IT was supported by postdoctoral fellowship from the Fondation ARC (http://www.arc-cancer.net) PDF20110603195., ANR-Blanc 2013 GERMPN, GERMPN, ANR-10-BLAN-1617, EPIGENOME, Formation, dynamics and epigenetic functions of 5-hydroxymethylcytosine residues in DNA.(2010), Hématopoïèse normale et pathologique (U1170 Inserm), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Tunis El Manar (UTM), Laboratoire d'hématologie moléculaire et cellulaire (LR11IPT07), Institut Pasteur de Tunis, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Stabilité Génétique et Oncogenèse (UMR 8200), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Centre National de la Recherche Scientifique (CNRS), Plateforme imagerie et cytométrie (PFIC), Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse (AMMICa), Centre National de la Recherche Scientifique (CNRS)-Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire d'Hématologie, Institut Pasteur de Tunis, This work was supported by grants from Agence Nationale de la Recherche (ANR-Blanc 2013 GERMPN) to IP and [ANR Blanc 2010 Project ANR-10-BLAN-1617] to IP and MS, Association pour la Recherche contre le Cancer (ARC) (ARC libre 2012) to IP, Electricité de France (http://www.edf.fr) RB 2014-26 to MS and Fondation de France (http://www.fondationdefrance.org) [#2012 00029161] to AAI. Labex GR-Ex (IP, WV) is funded by the program 'Investissements d’avenir'. EM was funded by INSERM/DGRST then a grant from Institut Pasteur from Tunis, Tunisia. LS were supported by Ph.D grants from the Cancéropôle Région Ile de France (DIM cellule souche). XC was supported by Ph.D MENRT grant. IT was supported by postdoctoral fellowship from the Fondation ARC., We thank the cytometry platform of Gustave Roussy (Y. Lecluse)., ANR-10-BLAN-1617,EPIGENOME,Formation, dynamics and epigenetic functions of 5-hydroxymethylcytosine residues in DNA.(2010), ANR-13-JSV1-0007,GERMPN,Etude des cas familiaux de néoplasmes myéloproliférifs: recherche des anomalies génétiques et de leurs fonctions.(2013), Pasteur Tunis, Institut, BLANC - Formation, dynamics and epigenetic functions of 5-hydroxymethylcytosine residues in DNA. - - EPIGENOME2010 - ANR-10-BLAN-1617 - BLANC - VALID, Jeunes Chercheuses et Jeunes Chercheurs - Etude des cas familiaux de néoplasmes myéloproliférifs: recherche des anomalies génétiques et de leurs fonctions. - - GERMPN2013 - ANR-13-JSV1-0007 - JC - VALID, and Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
0301 basic medicine ,DNA Repair ,Genetic instability ,MESH: Fibroblasts/cytology ,MESH: Tumor Suppressor Protein p53/metabolism ,MESH: Fibroblasts/metabolism ,MESH: Mutagenesis ,MESH: Base Sequence ,MESH: Thymine DNA Glycosylase/deficiency ,Biochemistry ,MESH: DNA Repair ,Epigenesis, Genetic ,S Phase ,MESH: Thymine DNA Glycosylase/genetics ,Mice ,chemistry.chemical_compound ,MESH: Genomic Instability ,MESH: DNA-Binding Proteins/genetics ,MESH: B-Lymphocytes/metabolism ,MESH: Animals ,MESH: Cytosine/metabolism ,MESH: Epigenesis, Genetic ,MESH: Megakaryocyte Progenitor Cells/cytology ,MESH: B-Lymphocytes/cytology ,B-Lymphocytes ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,MESH: Cytosine/analogs & derivatives ,MESH: S Phase ,Base excision repair ,DNA-Binding Proteins ,MESH: Proto-Oncogene Proteins/genetics ,5-hmC ,CpG site ,5-Methylcytosine ,[SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN] ,Cytosine ,Guanine ,MESH: Hydroxylation ,TDG ,Cell cycle ,Biology ,MESH: DNA-Binding Proteins/metabolism ,Hydroxylation ,Genomic Instability ,Cell Line ,Dioxygenases ,03 medical and health sciences ,MESH: Tumor Suppressor Protein p53/genetics ,[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN] ,Proto-Oncogene Proteins ,Animals ,Humans ,MESH: Mice ,[SDV.BC] Life Sciences [q-bio]/Cellular Biology ,Molecular Biology ,Megakaryocyte Progenitor Cells ,MESH: 5-Methylcytosine/analogs & derivatives ,5-Hydroxymethylcytosine ,TET2 ,MESH: Humans ,Base Sequence ,MESH: Proto-Oncogene Proteins/metabolism ,Mutagenesis ,MESH: 5-Methylcytosine/metabolism ,Cell Biology ,Fibroblasts ,Molecular biology ,Thymine DNA Glycosylase ,MESH: Cell Line ,030104 developmental biology ,DNA demethylation ,chemistry ,DNA glycosylase ,MESH: Megakaryocyte Progenitor Cells/metabolism ,Tumor Suppressor Protein p53 - Abstract
International audience; The family of Ten-Eleven Translocation (TET) proteins is implicated in the process of active DNA demethy-lation and thus in epigenetic regulation. TET 1, 2 and 3 proteins are oxygenases that can hydroxylate 5-methylcytosine (5-mC) into 5-hydroxymethylcytosine (5-hmC) and further oxidize 5-hmC into 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-caC). The base excision repair (BER) pathway removes the resulting 5-fC and 5-caC bases paired with a guanine and replaces them with regular cytosine. The question arises whether active modification of 5-mC residues and their subsequent elimination could affect the genomic DNA stability. Here, we generated two inducible cell lines (Ba/F3-EPOR, and UT7) over-expressing wild-type or catalytically inactive human TET2 proteins. Wild-type TET2 induction resulted in an increased level of 5-hmC and a cell cycle defect in S phase associated with higher level of phospho-rylated P53, chromosomal and centrosomal abnormalities. Furthermore, in a thymine-DNA glycosylase (Tdg) deficient context, the TET2-mediated increase of 5-hmC induces mutagenesis characterized by GC > AT transitions in CpG context suggesting a mutagenic potential of 5-hmC metabolites. Altogether, these data suggest that TET2 activity and the levels of 5-hmC and its derivatives should be tightly controlled to avoid genetic and chromosomal instabilities. Moreover, TET2-mediated active demethylation might be a very dangerous process if used to entirely demethylate the genome and might rather be used only at specific loci.
- Published
- 2016
- Full Text
- View/download PDF
15. HIV-1 Envelope Overcomes NLRP3-Mediated Inhibition of F-Actin Polymerization for Viral Entry
- Author
-
Haithem Dakhli, David M. Ojcius, Maxime Thoreau, Héla Saïdi, Eric Solary, Awatef Allouch, Jean-Luc Perfettini, Olivier Lambotte, Marina Caillet, Eric Deutsch, Olivier Delelis, Qiuji Wu, Zeinaf Muradova, Mauro Piacentini, Gianfranco Pancino, Roger Le Grand, Syed Qasim Raza, Audrey Paoletti, Asier Sáez-Cirión, Béatrice Poirier-Beaudouin, Nathalie Dereuddre-Bosquet, Frédéric Subra, Laurent Voisin, Guido Kroemer, Marie-Lise Gougeon, Roberta Nardacci, Frédéric Law, Radiothérapie moléculaire (UMR 1030), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Apoptose, cancer et immunité (U848), Immunité Anti-virale, Biothérapie et Vaccins (IABV), Institut Pasteur [Paris] (IP), Laboratoire de Biologie et de Pharmacologie Appliquée (LBPA), École normale supérieure - Cachan (ENS Cachan)-Centre National de la Recherche Scientifique (CNRS), Istituto Nazionale di Malattie Infettive 'Lazzaro Spallanzani' (INMI), Immunologie des Maladies Virales et Autoimmunes (IMVA - U1184), Université Paris-Sud - Paris 11 (UP11)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Infectious Diseases Models for Innovative Therapies (IDMIT), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, HIV, Inflammation et persistance - HIV, Inflammation and Persistence, University of the South Pacific (USP), Université Paris Diderot - Paris 7 (UPD7), Hématopoïèse normale et pathologique, Département de radiothérapie [Gustave Roussy], Institut Gustave Roussy (IGR), Università degli Studi di Roma Tor Vergata [Roma], Agence Nationale de la RechercheFrench National Research Agency (ANR) [ANR-10-IBHU-0001, ANR-10-LABX33, ANR-11-IDEX-003-01], Electricite de France, MIUR (FIRB)Ministero dell' Istruzione, dell' Universita e della Ricerca (MIUR), Ministry of Health of Italy 'Ricerca Finalizzata', ANR under the program 'Investissements d'Avenir'French National Research Agency (ANR) [ANR-10-LABX-33, ANR-11-IDEX-0003-01], Fondation Gustave Roussy, AIRCAssociazione Italiana per la Ricerca sul Cancro (AIRC), European Commission 'Transpath' Marie Curie Project, Agence Nationale de Recherche sur le Sida et sur les Hepatites (ANRSH)French National Research Agency (ANR), Higher Education Commission (Pakistan)Higher Education Commission of Pakistan, Laboratory of Excellence LERMIT, Institut National du CancerInstitut National du Cancer (INCA) France [INCA 9414], Canceropole Ile-de-FranceRegion Ile-de-France, Institut National du Cancer (INCa)Institut National du Cancer (INCA) France, NATIXIS, Sidaction, French National Agency for Research on AIDS and Viral Hepatitis (ANRSH)French National Research Agency (ANR), Ligue contre le Cancer (equipe labellisee), Agence National de la Recherche (ANR) -Projets blancsFrench National Research Agency (ANR), Institut Universitaire de France, Ministry of Health of Italy 'Ricerca Corrente', LabEx Immuno-Oncology, RHU Torino Lumiere, SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE), SIRIC Cancer Research and Personalized Medicine (CARPEM), MIUR (PRIN 2012)Ministero dell' Istruzione, dell' Universita e della Ricerca (MIUR), We gratefully acknowledge Y. Lecluse and S. Salome-Desnoulez for technical support., ANR-10-IBHU-0001,MMO (IHU-CANCER),Institut de Médecine Personnalisée du Cancer(2010), ANR-11-IDEX-0003,IPS,Idex Paris-Saclay(2011), European Project: 289964,EC:FP7:PEOPLE,FP7-PEOPLE-2011-ITN,TRANSPATH(2011), Leriche, Marianne, Instituts Hospitalo-Universitaires B - Institut de Médecine Personnalisée du Cancer - - MMO (IHU-CANCER)2010 - ANR-10-IBHU-0001 - IBHU - VALID, Idex Paris-Saclay - - IPS2011 - ANR-11-IDEX-0003 - IDEX - VALID, Transglutaminase in disease: a novel therapeutic target? - TRANSPATH - - EC:FP7:PEOPLE2011-11-01 - 2015-10-31 - 289964 - VALID, Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Gustave Roussy (IGR)-Université Paris-Sud - Paris 11 (UP11), Institut Pasteur [Paris], and HIV, Inflammation et persistance
- Subjects
0301 basic medicine ,CBL ,Settore BIO/06 ,CXCR4 ,General Biochemistry, Genetics and Molecular Biology ,HIV ,NLRP3 ,P2Y2 ,inflammasome ,viral entry ,Polymerization ,03 medical and health sciences ,0302 clinical medicine ,Viral entry ,NLR Family, Pyrin Domain-Containing 3 Protein ,medicine ,Humans ,[INFO.INFO-DL]Computer Science [cs]/Digital Libraries [cs.DL] ,Receptor ,lcsh:QH301-705.5 ,Actin ,biology ,integumentary system ,Chemistry ,Purinergic receptor ,Inflammasome ,Virus Internalization ,Actins ,3. Good health ,Cell biology ,Ubiquitin ligase ,030104 developmental biology ,lcsh:Biology (General) ,biology.protein ,HIV-1 ,Phosphorylation ,[INFO.INFO-DL] Computer Science [cs]/Digital Libraries [cs.DL] ,030217 neurology & neurosurgery ,medicine.drug ,Signal Transduction - Abstract
Summary: Purinergic receptors and nucleotide-binding domain leucine-rich repeat containing (NLR) proteins have been shown to control viral infection. Here, we show that the NLR family member NLRP3 and the purinergic receptor P2Y2 constitutively interact and regulate susceptibility to HIV-1 infection. We found that NLRP3 acts as an inhibitory factor of viral entry that represses F-actin remodeling. The binding of the HIV-1 envelope to its host cell receptors (CD4, CXCR4, and/or CCR5) overcomes this restriction by stimulating P2Y2. Once activated, P2Y2 enhances its interaction with NLRP3 and stimulates the recruitment of the E3 ubiquitin ligase CBL to NLRP3, ultimately leading to NLRP3 degradation. NLRP3 degradation is permissive for PYK2 phosphorylation (PYK2Y402∗) and subsequent F-actin polymerization, which is required for the entry of HIV-1 into host cells. Taken together, our results uncover a mechanism by which HIV-1 overcomes NLRP3 restriction that appears essential for the accomplishment of the early steps of HIV-1 entry. : Paoletti et al. identified a constitutive interaction between NLRP3 and P2Y2 that regulates HIV-1 entry into target cells. They revealed that NLRP3 represses viral entry by impairing F-actin reorganization. HIV-1 overcomes this host cellular resistance by inducing NLRP3 degradation through the activation of P2Y2-dependent signaling pathway. Keywords: NLRP3, P2Y2, CBL, inflammasome, viral entry, HIV
- Published
- 2019
- Full Text
- View/download PDF
16. Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death
- Author
-
Martins, Isabelle, Raza, Syed Qasim, Voisin, Laurent, Dakhli, Haithem, Allouch, Awatef, Law, Frédéric, Sabino, Dora, De Jong, Dorine, Thoreau, Maxime, Mintet, Elodie, Dugué, Delphine, Piacentini, Mauro, Gougeon, Marie-Lise, Jaulin, Fanny, Bertrand, Pascale, Brenner, Catherine, Ojcius, David M, Kroemer, Guido, Modjtahedi, Nazanine, Deutsch, Eric, Perfettini, Jean-Luc, Radiothérapie moléculaire (UMR 1030), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris-Saclay, University of Veterinary and Animal Sciences [Lahore, Pakistan] (UVAS), Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse (U981), National Institute for Infectious Diseases 'Lazzaro Spallanzani', Università degli Studi di Roma Tor Vergata [Roma], Immunité Anti-virale, Biothérapie et Vaccins (IABV), Institut Pasteur [Paris] (IP), Laboratoire Réparation Et Vieillissement (LREV), Université Paris-Sud - Paris 11 (UP11)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Biologie François JACOB (JACOB), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Signalisation et physiopathologie cardiaque, Université Paris-Sud - Paris 11 (UP11)-IFR141-Institut National de la Santé et de la Recherche Médicale (INSERM), University of the Pacific [San Francisco], University of the Pacific, Apoptose, cancer et immunité (Equipe labellisée Ligue contre le cancer - CRC - Inserm U1138), Institut Gustave Roussy (IGR)-Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Karolinska University Hospital [Stockholm], Pôle de biologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Plateforme de métabolomique, Direction de la recherche [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), This work was supported by funds from La Ligue contre le Cancer Comité du Val-de-Marne, Agence Nationale de la Recherche (ANR), Institut National du Cancer (INCA-2015-1-PLBIO-07-IGR-1), Laboratory of Excellence (LabEx) LERMIT, the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE), NATIXIS, Electricité de France and Fondation Gustave Roussy (to J-L.P.), and from the Ligue contre le Cancer Comité de Charente-Maritime (équipe labelisée), Agence National de la Recherche (ANR) – Projets blancs, ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases, Association pour la Recherche sur le Cancer (ARC), Cancéropôle Ile-de-France, Chancelerie des universités de Paris (Legs Poix), Fondation pour la Recherche Médicale (FRM), a donation by Elior, the European Commission (ArtForce), the European Research Council (ERC), Fondation Carrefour, Institut National du Cancer (INCa), Inserm (HTE), Institut Universitaire de France, LeDucq Foundation, the LabEx Immuno-Oncology, the RHU Torino Lumière, the Searave Foundation, the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE), the SIRIC Cancer Research and Personalized Medicine (CARPEM), and the Paris Alliance of Cancer Research Institutes (PACRI) (to G.K.). I.M. is supported by the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE) and INCA (INCA-DGOS-INSERM 6043). S.Q.R is funded by Higher Education Commission (Pakistan) and by the Laboratory of Excellence LERMIT with a grant from ANR (ANR-10-LABX-33) under the program 'Investissements d’Avenir' ANR-11-IDEX-0003-01. E.M. and M.T. are also supported by the Laboratory of Excellence LERMIT with a grant from ANR (ANR-10-LABX-33) under the program 'Investissements d’Avenir' ANR-11-IDEX-0003-01. L.V. is funded by a grant from INCA (INCA-2015-1-PLBIO-07-IGR-1). H.D and D.D are, respectively, recipients of PhD fellowships from LabEx LERMIT and Fondation Philantropia. Q.W. is supported by China Scholarship Council., The authors would like to thank C. Leteur, Y. Lecluse, P. Rameau, and S. Salome-Desnoulez for their technical supports., Institut Pasteur [Paris], École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-École pratique des hautes études (EPHE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Gustave Roussy (IGR)-Université Paris-Sud - Paris 11 (UP11), and Université Paris Diderot - Paris 7 (UPD7)-Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Biologie François JACOB (JACOB)
- Subjects
Settore BIO/06 ,Paclitaxel ,Oncology and Carcinogenesis ,Antineoplastic Agents ,Apoptosis ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,[SDV.BC]Life Sciences [q-bio]/Cellular Biology ,Cell Line ,Jurkat Cells ,Mice ,Cell Line, Tumor ,Neoplasms ,Breast Cancer ,Animals ,Humans ,lcsh:QH573-671 ,Cancer ,Tumor ,Radiotherapy ,Cell Death ,lcsh:Cytology ,Bystander Effect ,HCT116 Cells ,Oxaliplatin ,Gamma Rays ,MCF-7 Cells ,Biochemistry and Cell Biology ,Cisplatin - Abstract
International audience; Even though cell death modalities elicited by anticancer chemotherapy and radiotherapy have been extensively studied, the ability of anticancer treatments to induce non-cell-autonomous death has never been investigated. By means of multispectral imaging flow-cytometry-based technology, we analyzed the lethal fate of cancer cells that were treated with conventional anticancer agents and co-cultured with untreated cells, observing that anticancer agents can simultaneously trigger cell-autonomous and non-cell-autonomous death in treated and untreated cells. After ionizing radiation, oxaliplatin, or cisplatin treatment, fractions of treated cancer cell populations were eliminated through cell-autonomous death mechanisms, while other fractions of the treated cancer cells engulfed and killed neighboring cells through non-cell-autonomous processes, including cellular cannibalism. Under conditions of treatment with paclitaxel, non-cell-autonomous and cell-autonomous death were both detected in the treated cell population, while untreated neighboring cells exhibited features of apoptotic demise. The transcriptional activity of p53 tumor-suppressor protein contributed to the execution of cell-autonomous death, yet failed to affect the non-cell-autonomous death by cannibalism for the majority of tested anticancer agents, indicating that the induction of non-cell-autonomous death can occur under conditions in which cell-autonomous death was impaired. Altogether, these results reveal that chemotherapy and radiotherapy can induce both non-cell-autonomous and cell-autonomous death of cancer cells, highlighting the heterogeneity of cell death responses to anticancer treatments and the unsuspected potential contribution of non-cell-autonomous death to the global effects of anticancer treatment.
- Published
- 2018
- Full Text
- View/download PDF
17. Senescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cells
- Author
-
Oliver Bischof, Virginie Penard-Lacronique, Elena Mylonas, Cyril Quiveron, Michela Esposito, Laure Delestré, Christel Guillouf, Hengxiang Cui, Institut Gustave Roussy (IGR), Dynamique moléculaire de la transformation hématopoïétique (Dynamo), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Organisation Nucléaire et Oncogenèse / Nuclear Organization and Oncogenesis, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), This work was supported by the Fondation de France, Inserm, the Institut National du Cancer (INCa-DGOS-INSERM 6043 and PL-BIO-06), ITMO Cancer de l’alliance nationale pour les sciences de la vie et de la santé (AVIESAN), Section régionale de la Ligue Nationale contre le Cancer. L. Delestré was supported by AVIESAN and Fondation de France, H. Cui by Cancéropole Ile-de-France, M. Esposito by the Institut National du Cancer (PL-BIO-06). Quiveron and E. Mylonas by a CDI-Mission (Institut Gustave Roussy)., The authors would like to thank Y. Lecluse, P. Rameau and Z. Maciorowski from the cytometry platform and A. Nicolas, P. Opolon, O. Bawa, S. Arrufat, R. Corre and E. Louvet from the IHC platform. We thank the animal facility housing at Curie and Gustave Roussy Institutes. We thank O. Bernard, M. David for comments on the manuscript and F. Rosselli and F. Moreau-Gachelin for helpful scientific discussions and critical reading of the manuscript., Cheriet Rauline, Samia, and Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
0301 basic medicine ,Myeloid ,[SDV]Life Sciences [q-bio] ,Ectopic Gene Expression ,MESH: Hematopoietic Stem Cells ,Mice ,Bone Marrow ,hemic and lymphatic diseases ,MESH: Animals ,Cellular Senescence ,Leukemia ,Myeloid leukemia ,Hematology ,Immunohistochemistry ,DNA-Binding Proteins ,[SDV] Life Sciences [q-bio] ,Haematopoiesis ,medicine.anatomical_structure ,MESH: Ectopic Gene Expression ,MESH: Bone Marrow ,Stem cell ,Acute Myeloid Leukemia ,Senescence ,MESH: Mutation ,MESH: Mice, Transgenic ,MESH: Trans-Activators ,Mice, Transgenic ,Biology ,Article ,Cell Line ,03 medical and health sciences ,Proto-Oncogene Proteins ,MESH: Cell Proliferation ,MESH: Leukemia ,medicine ,Animals ,Humans ,MESH: Mice ,Cell Proliferation ,MESH: Humans ,MESH: Immunohistochemistry ,MESH: Cellular Senescence ,Fibroblasts ,Hematopoietic Stem Cells ,medicine.disease ,MESH: Cell Line ,MESH: Proto-Oncogene Proteins ,030104 developmental biology ,Cell culture ,MESH: Fibroblasts ,Mutation ,Trans-Activators ,Cancer research ,MESH: Biomarkers ,Bone marrow ,Biomarkers ,MESH: DNA-Binding Proteins - Abstract
International audience; Transcriptional deregulation caused by epigenetic or genetic alterations is a major cause of leukemic transformation. The Spi1/PU.1 transcription factor is a key regulator of many steps of hematopoiesis, and limits self-renewal of hematopoietic stem cells. The deregulation of its expression or activity contributes to leukemia, in which Spi1 can be either an oncogene or a tumor suppressor. Herein we explored whether cellular senescence, an anti-tumoral pathway that restrains cell proliferation, is a mechanism by which Spi1 limits hematopoietic cell expansion, and thus prevents the development of leukemia. We show that Spi1 overexpression triggers cellular senescence both in primary fibroblasts and hematopoietic cells. Erythroid and myeloid lineages are both prone to Spi1-induced senescence. In hematopoietic cells, Spi1-induced senescence requires its DNA-binding activity and a functional p38MAPK14 pathway but is independent of a DNA-damage response. In contrast, in fibroblasts, Spi1-induced senescence is triggered by a DNA-damage response. Importantly, using our well-established Spi1 transgenic leukemia mouse model, we demonstrate that Spi1 overexpression also induces senescence in erythroid progenitors of the bone marrow in vivo before the onset of the pre-leukemic phase of erythroleukemia. Remarkably, the senescence response is lost during the progression of the disease and erythroid blasts do not display a higher expression of Dec1 and CDKN1A, two of the induced senescence markers in young animals. These results bring indirect evidence that leukemia develops from cells which have bypassed Spi1-induced senescence. Overall, our results reveal senescence as a Spi1-induced anti-proliferative mechanism that may be a safeguard against the development of acute myeloid leukemia.
- Published
- 2017
- Full Text
- View/download PDF
18. NOX2-dependent ATM kinase activation dictates pro-inflammatory macrophage phenotype and improves effectiveness to radiation therapy
- Author
-
Laurent Voisin, Céline Leteur, Fabien Milliat, Eric Deutsch, Qiuji Wu, Eric Solary, Zeinaf Muradova, Haithem Dakhli, Audrey Paoletti, Awatef Allouch, Jean-Luc Perfettini, Filippo Rosselli, Frédéric Law, Mélanie Gauthier, David M. Ojcius, Maxime Thoreau, Elodie Mintet, Nazanine Modjtahedi, Olivier Caron, Isabelle Martins, Céline Mirjolet, Radiothérapie moléculaire (UMR 1030), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Gustave Roussy (IGR)-Université Paris-Sud - Paris 11 (UP11), Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER, Institut Jacques Monod (IJM (UMR_7592)), Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Institut Cochin (IC UM3 (UMR 8104 / U1016)), Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche en Informatique, Signal et Automatique de Lille - UMR 9189 (CRIStAL), Centrale Lille-Université de Lille-Centre National de la Recherche Scientifique (CNRS), Institut de radioprotection et de sûreté nucléaire [Fontenay-aux-Roses] (IRSN), Ministère de l'économie, de l'industrie et de l'emploi-Ministère de la Défense-Ministère de la santé-Ministère de l'Enseignement Supérieur et de la Recherche Scientifique-Ministère de l'écologie de l'Energie, du Développement durable et de l'Aménagement du territoire, University of California [Merced], University of California, Stabilité Génétique et Oncogenèse (UMR 8200), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Centre National de la Recherche Scientifique (CNRS), Apoptose, cancer et immunité (U848), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Radiothérapie moléculaire [UMR 1030], Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] [UNICANCER/CRLCC-CGFL], Institut Jacques Monod [IJM (UMR_7592)], Institut Cochin [IC UM3 (UMR 8104 / U1016)], Centre de Recherche en Informatique, Signal et Automatique de Lille - UMR 9189 [CRIStAL], University of California [Merced] [UC Merced], Stabilité Génétique et Oncogenèse [UMR 8200], Apoptose, cancer et immunité [U848], Institut Gustave Roussy (IGR), Systerel, Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Onco-génétique, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Laboratoire de Radiopathologie, Génomes et cancer (GC (FRE2939)), Hématopoïèse normale et pathologique, This work was supported by funds from Agence Nationale de la Recherche (ANR-10-IBHU-0001, ANR-10-LABX33 and ANR-11-IDEX-003-01), Electricité de France, Fondation Gustave Roussy, Institut National du Cancer (INCA 9414), NATIXIS, SIDACTION and the French National Agency for Research on AIDS and viral Hepatitis (ANRSH) (to J-LP.), Electricité de France and Fondation Gustave Roussy (to ED). QW is recipient of PhD fellowship of China Scholarship Council. AP and AA are, respectively, recipient of PhD fellowship and post-doc fellowship from Agence Nationale de Recherche sur le Sida et sur les Hépatites (ANRSH). LV and FL are recipient of PhD fellowships from Fondation pour la Recherche Médicale and CIFRE. HD, EM and MT are supported by the Laboratory of Excellence LERMIT with a grant from ANR (ANR-10-LABX-33) under the program ‘Investissements d'Avenir’ ANR-11-IDEX-0003-01. IM is funded by INCA (INCA-DGOS-INSERM 6043). CM work was supported by the ‘Cancéropôle Grand Est’, and the ‘Conseils Régionaux de Bourgogne, de Franche Comté et de Lorraine’., We gratefully acknowledge S Solier, Y Lecluse and S Salome-Desnoulez for technical support., Centre Régional de Lutte contre le cancer - Centre Georges-François Leclerc (CRLCC - CGFL), Centre de Recherche en Informatique, Signal et Automatique de Lille (CRIStAL) - UMR 9189 (CRIStAL), Centre National de la Recherche Scientifique (CNRS)-Université de Lille-Ecole Centrale de Lille, and Ministère de l'écologie de l'Energie, du Développement durable et de l'Aménagement du territoire-Ministère de la santé-Ministère de la Défense-Ministère de l'Enseignement Supérieur et de la Recherche Scientifique-Ministère de l'économie, de l'industrie et de l'emploi
- Subjects
0301 basic medicine ,[SDV]Life Sciences [q-bio] ,Ataxia Telangiectasia Mutated Proteins ,Neurodegenerative ,Medical and Health Sciences ,Mice ,0302 clinical medicine ,Macrophage ,Phosphorylation ,ComputingMilieux_MISCELLANEOUS ,Cancer ,Microscopy ,NADPH oxidase ,biology ,Kinase ,Biological Sciences ,Flow Cytometry ,3. Good health ,Cell biology ,030220 oncology & carcinogenesis ,Signal transduction ,Signal Transduction ,Biochemistry & Molecular Biology ,Fluorescence ,Cell Line ,03 medical and health sciences ,Interferon-gamma ,Ataxia Telangiectasia ,Rare Diseases ,Genetics ,Animals ,Humans ,Molecular Biology ,Protein Processing ,Original Paper ,Macrophages ,Post-Translational ,Cell Biology ,Macrophage Activation ,030104 developmental biology ,RAW 264.7 Cells ,Microscopy, Fluorescence ,Apoptosis ,biology.protein ,Cancer research ,Protein Processing, Post-Translational ,IRF5 ,Interferon regulatory factors - Abstract
International audience; Although tumor-associated macrophages have been extensively studied in the control of response to radiotherapy, the molecular mechanisms involved in the ionizing radiation-mediated activation of macrophages remain elusive. Here we show that ionizing radiation induces the expression of interferon regulatory factor 5 (IRF5) promoting thus macrophage activation toward a pro-inflammatory phenotype. We reveal that the activation of the ataxia telangiectasia mutated (ATM) kinase is required for ionizing radiation-elicited macrophage activation, but also for macrophage reprogramming after treatments with γ-interferon, lipopolysaccharide or chemotherapeutic agent (such as cisplatin), underscoring the fact that the kinase ATM plays a central role during macrophage phenotypic switching toward a pro-inflammatory phenotype through the regulation of mRNA level and post-translational modifications of IRF5. We further demonstrate that NADPH oxidase 2 (NOX2)-dependent ROS production is upstream to ATM activation and is essential during this process. We also report that the inhibition of any component of this signaling pathway (NOX2, ROS and ATM) impairs pro-inflammatory activation of macrophages and predicts a poor tumor response to preoperative radiotherapy in locally advanced rectal cancer. Altogether, our results identify a novel signaling pathway involved in macrophage activation that may enhance the effectiveness of radiotherapy through the reprogramming of tumor-infiltrating macrophages.
- Published
- 2017
- Full Text
- View/download PDF
19. The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300-dependent stemness program.
- Author
-
Fagnan A, Aid Z, Baille M, Drakul A, Robert E, Lopez CK, Thirant C, Lecluse Y, Rivière J, Ignacimouttou C, Salmoiraghi S, Anguita E, Naimo A, Marzac C, Pflumio F, Malinge S, Wichmann C, Huang Y, Lobry C, Chaumeil J, Soler E, Bourquin JP, Nerlov C, Bernard OA, Schwaller J, and Mercher T
- Abstract
Transcriptional cofactors of the ETO family are recurrent fusion partners in acute leukemia. We characterized the ETO2 regulome by integrating transcriptomic and chromatin binding analyses in human erythroleukemia xenografts and controlled ETO2 depletion models. We demonstrate that beyond its well-established repressive activity, ETO2 directly activates transcription of MYB, among other genes. The ETO2-activated signature is associated with a poorer prognosis in erythroleukemia but also in other acute myeloid and lymphoid leukemia subtypes. Mechanistically, ETO2 colocalizes with EP300 and MYB at enhancers supporting the existence of an ETO2/MYB feedforward transcription activation loop (e.g., on MYB itself). Both small-molecule and PROTAC-mediated inhibition of EP300 acetyltransferases strongly reduced ETO2 protein, chromatin binding, and ETO2-activated transcripts. Taken together, our data show that ETO2 positively enforces a leukemia maintenance program that is mediated in part by the MYB transcription factor and that relies on acetyltransferase cofactors to stabilize ETO2 scaffolding activity., Competing Interests: The authors declare no conflict of interest., (© 2024 The Author(s). HemaSphere published by John Wiley & Sons Ltd on behalf of European Hematology Association.)
- Published
- 2024
- Full Text
- View/download PDF
20. Agricultural exposures and DNA damage in PBMC of female farmers measured using the alkaline comet assay.
- Author
-
Evenden P, Vandoolaeghe Q, Lecluse Y, Gac AC, Delépée R, Weiswald LB, Boutet-Robinet E, Boulanger M, Bonassi S, Lebailly P, and Meryet-Figuière M
- Subjects
- Female, Humans, Animals, Cattle, Swine, Comet Assay, Farmers, DNA Damage, Agriculture, Leukocytes, Mononuclear, Occupational Exposure adverse effects
- Abstract
Objective: Several studies investigated the link between agricultural occupational exposures and DNA damage, in an attempt to bring elements of biological plausibility to the increased cancer risk associated with them. However, only a few of these studies focused on females., Methods: The comet assay was performed on PBMC (Peripheral Blood Mononuclear Cells) samples from 245 females working in open field farming and cattle raising, located in the Normandy area of France. Individual questionnaires on tasks performed were administered at the time of sampling to directly assess exposures. Environmental exposures were issued from a questionnaire assessing the farm productions. Linear regression analyses were done using the DNA damage scores., Results: Regarding direct exposures, several tasks associated with exposure to potentially harmful chemicals were not associated with DNA damage, but a longer duration of use of herbicide on meadows (p = 0.05) or of cleaning and upkeep of agricultural equipment (p = 0.06) revealed higher DNA damage levels, although the number of exposed women was low. Several indirect and/or environmental exposures were associated with DNA damage in multivariate analyses: a larger surface of meadows (p = 0.006) or the presence of poultry (p = 0.03) was associated with less DNA damage, while the presence of swine (p = 0.01) was associated with higher DNA damage. Smokers and former smokers had less DNA damage than non-smokers (p = 0.0008 and p = 0.03)., Conclusions: We report modified levels of DNA damage for those environmentally exposed to meadows, poultry and pig farming, underlining the need for a better knowledge of the potential health risks experienced by females in this setting., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
21. Pesticide exposure in greenspaces: Comparing field measurement of dermal contamination with values predicted by registration models.
- Author
-
de Graaf L, Bresson M, Boulanger M, Bureau M, Lecluse Y, Lebailly P, and Baldi I
- Subjects
- Parks, Recreational, Agriculture, Glyphosate, Pesticides analysis, Occupational Exposure analysis
- Abstract
Since 2014, the Agricultural Operator Exposure Model (AOEM) has been the harmonised European model used for estimating non-dietary operator exposure to pesticide. It is based on studies conducted by the pesticide companies and it features 13 different crops including non-agricultural areas such as amenity grasslands. The objective of this study was to compare the dermal exposure measured during a field study conducted in a non-agricultural area with the corresponding values estimated by the model AOEM. The non-controlled field study was conducted in France in 2011 and included 24 private and public gardeners who apply glyphosate with knapsack sprayers. Dermal exposure was measured using the whole-body method and cotton gloves. Each measured value had an estimated value given by AOEM and we tested their correlation using linear regression. The model overestimated body exposure for all observations and there was no correlation between values. However, it underestimated hand exposure by 42 times and it systematically underestimated the exposure when the operators were wearing gloves, especially during the application. The model failed at being conservative regarding hand exposure and highly overestimated the protection afforded by the gloves. At a time of glyphosate renewed approval in Europe, non-controlled field studies conducted by academics are needed to improve AOEM model, especially in the non-agricultural sector. Indeed, among the 34 studies included in the model, none were conducted on a non-agricultural area and only four assessed the exposure when using a knapsack sprayer. Moreover, knapsack sprayers being the main equipment used worldwide in both agricultural and non-agricultural settings, it is also crucial to integrate new data specific to this equipment in the model. Operator exposure should be estimated with accuracy in the registration process of pesticides to ensure proper safety as well as in epidemiological studies to improve exposure assessment., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
22. Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.
- Author
-
Mezquita L, Oulhen M, Aberlenc A, Deloger M, Aldea M, Honore A, Lecluse Y, Howarth K, Friboulet L, Besse B, Planchard D, and Farace F
- Subjects
- Humans, Proto-Oncogene Proteins B-raf genetics, Mutation, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Non-Small-Cell Lung genetics, Carcinoma, Non-Small-Cell Lung pathology, Lung Neoplasms drug therapy, Lung Neoplasms genetics, Lung Neoplasms pathology, Neoplastic Cells, Circulating pathology, Cell-Free Nucleic Acids
- Abstract
Background: Resistance mechanisms to combination therapy with dabrafenib plus trametinib remain poorly understood in patients with BRAF
V600E -mutant advanced non-small-cell lung cancer (NSCLC). We examined resistance to BRAF inhibition by single CTC sequencing in BRAFV600E -mutant NSCLC., Methods: CTCs and cfDNA were examined in seven BRAFV600E -mutant NSCLC patients at failure to treatment. Matched tumour tissue was available for four patients. Single CTCs were isolated by fluorescence-activated cell sorting following enrichment and immunofluorescence (Hoechst 33342/CD45/pan-cytokeratins) and sequenced for mutation and copy number-alteration (CNA) analyses., Results: BRAFV600E was found in 4/4 tumour biopsies and 5/7 cfDNA samples. CTC mutations were mostly found in MAPK-independent pathways and only 1/26 CTCs were BRAFV600E mutated. CTC profiles encompassed the majority of matched tumour biopsy CNAs but 72.5% to 84.5% of CTC CNAs were exclusive to CTCs. Extensive diversity, involving MAPK, MAPK-related, cell cycle, DNA repair and immune response pathways, was observed in CTCs and missed by analyses on tumour biopsies and cfDNA. Driver alterations in clinically relevant genes were recurrent in CTCs., Conclusions: Resistance was not driven by BRAFV600E -mutant CTCs. Extensive tumour genomic heterogeneity was found in CTCs compared to tumour biopsies and cfDNA at failure to BRAF inhibition, in BRAFV600E -mutant NSCLC, including relevant alterations that may represent potential treatment opportunities., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
23. Herbicide exposure during occupational knapsack spraying in French gardeners and municipal workers.
- Author
-
Boulanger M, de Graaf L, Pons R, Bouchart V, Bureau M, Lecluse Y, Meryet-Figuiere M, Tual S, Baldi I, and Lebailly P
- Subjects
- Humans, Male, Agriculture, Hand, Herbicides, Occupational Exposure analysis, Pesticides analysis
- Abstract
Context: There is a lack of data on pesticide exposure levels during spraying with a knapsack, while it could have important implications for their users' health., Methods: We assessed levels and determinants of exposure in 24 male private landscapers/gardeners and municipal workers in France in 2011. Actual dermal exposure to glyphosate was assessed with cotton undergarments and gloves, and a cotton coverall changed between mixing and spraying to assess the contribution of each phase and body area to overall contamination. A field monitor observed the whole workshift and filled in a standardized observation grid., Results: The median actual contamination was 5,256 µg for the body, and 4,620 µg for hands. Spraying was more exposing than mixing/loading for all body parts except hands, which contributed to nearly 90% of body exposure during mixing/loading, and 30% during spraying, followed by back (14%). In the most exposed quartile, levels were close to some observations in agriculture., Conclusion: Our study provides new data on pesticide exposure levels of knapsack sprayer users; it should lead to a reinforced prevention, in order to make exposures as low as possible and lessen the risk of chronic diseases., (© The Author(s) 2023. Published by Oxford University Press on behalf of the British Occupational Hygiene Society.)
- Published
- 2023
- Full Text
- View/download PDF
24. High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.
- Author
-
Aid Z, Robert E, Lopez CK, Bourgoin M, Boudia F, Le Mene M, Riviere J, Baille M, Benbarche S, Renou L, Fagnan A, Thirant C, Federici L, Touchard L, Lecluse Y, Jetten A, Geoerger B, Lapillonne H, Solary E, Gaudry M, Meshinchi S, Pflumio F, Auberger P, Lobry C, Petit A, Jacquel A, and Mercher T
- Subjects
- Child, Humans, Caspase 3, Myeloid Cell Leukemia Sequence 1 Protein genetics, Prognosis, Proto-Oncogene Proteins c-bcl-2 genetics, Proto-Oncogene Proteins c-bcl-2 metabolism, Leukemia, Myeloid, Transcription Factors
- Abstract
Pediatric acute myeloid leukemia expressing the ETO2::GLIS2 fusion oncogene is associated with dismal prognosis. Previous studies have shown that ETO2::GLIS2 can efficiently induce leukemia development associated with strong transcriptional changes but those amenable to pharmacological targeting remained to be identified. By studying an inducible ETO2::GLIS2 cellular model, we uncovered that de novo ETO2::GLIS2 expression in human cells led to increased CASP3 transcription, CASP3 activation, and cell death. Patient-derived ETO2::GLIS2
+ leukemic cells expressed both high CASP3 and high BCL2. While BCL2 inhibition partly inhibited ETO2::GLIS2+ leukemic cell proliferation, BH3 profiling revealed that it also sensitized these cells to MCL1 inhibition indicating a functional redundancy between BCL2 and MCL1. We further show that combined inhibition of BCL2 and MCL1 is mandatory to abrogate disease progression using in vivo patient-derived xenograft models. These data reveal that a transcriptional consequence of ETO2::GLIS2 expression includes a positive regulation of the pro-apoptotic CASP3 and associates with a vulnerability to combined targeting of two BCL2 family members providing a novel therapeutic perspective for this aggressive pediatric AML subgroup., (© 2022. The Author(s), under exclusive licence to Springer Nature Limited.)- Published
- 2023
- Full Text
- View/download PDF
25. CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia.
- Author
-
Allouch A, Voisin L, Zhang Y, Raza SQ, Lecluse Y, Calvo J, Selimoglu-Buet D, de Botton S, Louache F, Pflumio F, Solary E, and Perfettini JL
- Subjects
- Humans, Mice, Animals, Immunotherapy, Macrophages metabolism, Cyclin-Dependent Kinase Inhibitor p21 genetics, Cyclin-Dependent Kinase Inhibitor p21 metabolism, Phagocytosis, Leukemia, Myeloid, Acute pathology
- Abstract
Targeting the reprogramming and phagocytic capacities of tumor-associated macrophages (TAMs) has emerged as a therapeutic opportunity for cancer treatment. Here, we demonstrate that tumor cell phagocytosis drives the pro-inflammatory activation of TAMs and identify a key role for the cyclin-dependent kinase inhibitor CDKN1A (p21). Through the transcriptional repression of Signal-Regularity Protein α (SIRPα), p21 promotes leukemia cell phagocytosis and, subsequently, the pro-inflammatory reprogramming of phagocytic macrophages that extends to surrounding macrophages through Interferon γ. In mouse models of human T-cell acute lymphoblastic leukemia (T-ALL), infusion of human monocytes (Mos) engineered to overexpress p21 (p21TD-Mos) leads to Mo differentiation into phagocytosis-proficient TAMs that, after leukemia cell engulfment, undergo pro-inflammatory activation and trigger the reprogramming of bystander TAMs, reducing the leukemic burden and substantially prolonging survival in mice. These results reveal p21 as a trigger of phagocytosis-guided pro-inflammatory TAM reprogramming and highlight the potential for p21TD-Mo-based cellular therapy as a cancer immunotherapy., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
26. Pesticide exposure of workers in apple growing in France.
- Author
-
Bureau M, Béziat B, Duporté G, Bouchart V, Lecluse Y, Barron E, Garrigou A, Dévier MH, Budzinski H, Lebailly P, and Baldi I
- Subjects
- Captan analysis, Humans, Seasons, Malus, Occupational Exposure analysis, Pesticides
- Abstract
Objective: Although apple trees are heavily sprayed, few studies have assessed the pesticide exposure of operators and workers in apple orchards. However, these data are crucial for assessing the health impact of such exposures. The aim of this study was to measure pesticide exposure in apple growing according to tasks and body parts., Methods: A non-controlled field study was conducted in apple orchards in 4 regions of France during the 2016 and 2017 treatment seasons. Workers' external contamination and their determinants were assessed over 156 working days corresponding to 30 treatment days, 68 re-entry days and 58 harvesting days. We measured pesticide dermal contamination during each task and made detailed observations of work characteristics throughout the day. Captan and dithianon were used as markers of exposure., Results: The median dermal contamination per day was 5.50 mg of captan and 3.33 mg of dithianon for operators, 24.39 mg of captan and 1.84 mg of dithianon for re-entry workers, and 5.82 mg of captan and 0.74 mg of dithianon for harvesters. Thus, workers performing re-entry tasks, especially thinning and anti-hail net opening, presented higher contamination, either equal to or higher than in operators. For these last ones, mixing/loading and equipment cleaning were the most contaminating tasks. Most of the contamination was observed on workers' hands in all tasks, except for net-opening in which their heads accounted for the most daily contamination., Conclusions: This study highlights the importance of taking indirect exposures into account during re-entry work in apple growing., (© 2021. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
27. Pesticide Exposure in Fruit-Growers: Comparing Levels and Determinants Assessed under Usual Conditions of Work (CANEPA Study) with Those Predicted by Registration Process (Agricultural Operator Exposure Model).
- Author
-
Bresson M, Bureau M, Le Goff J, Lecluse Y, Robelot E, Delamare J, Baldi I, and Lebailly P
- Subjects
- Agriculture, Farmers, Fruit chemistry, Humans, Malus, Occupational Exposure analysis, Pesticides analysis
- Abstract
Knowledge of pesticide exposure levels in farmers is necessary for epidemiological studies and regulatory purposes. In the European pesticide registration process, operators' exposure is predicted using the Agricultural Operator Exposure Model (AOEM), created in 2014 by the European Food Safety Authority based on studies conducted by the pesticide industry. We compared operators' exposures during treatment days in the apple-growing industry under non-controlled working conditions and AOEM-predicted values. The dermal exposure of thirty French apple-growers from the CANEPA study when applying two fungicides was measured using body patches and cotton gloves. For each observation, the corresponding exposure was calculated by means of the AOEM, using data recorded about the operator, spraying equipment and personal protective equipment (PPE) used. A significant linear correlation was observed between calculated and measured daily exposures. The model overestimated the daily exposure approximately 4-fold and the exposure during application 10-fold. However, exposure was underestimated during mixing/loading for 70% of the observations when the operator wore PPE. The AOEM did not overestimate exposures in all circumstances, especially during mixing/loading, when operators handle concentrated products. The protection provided by PPE appeared to be overestimated. This could be due to the optimal working conditions under which the "industrial" studies are conducted, which may not be representative of real working conditions of operators in fruit-growing.
- Published
- 2022
- Full Text
- View/download PDF
28. Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.
- Author
-
Oulhen M, Pawlikowska P, Tayoun T, Garonzi M, Buson G, Forcato C, Manaresi N, Aberlenc A, Mezquita L, Lecluse Y, Lavaud P, Naltet C, Planchard D, Besse B, and Farace F
- Abstract
Gatekeeper mutations are identified in only 50% of the cases at resistance to Anaplastic Lymphoma Kinase (ALK)-tyrosine kinase inhibitors (TKIs). Circulating tumor cells (CTCs) are relevant tools to identify additional resistance mechanisms and can be sequenced at the single-cell level. Here, we provide in-depth investigation of copy number alteration (CNA) heterogeneity in phenotypically characterized CTCs at resistance to ALK-TKIs in ALK-positive non-small cell lung cancer. Single CTC isolation and phenotyping were performed by DEPArray or fluorescence-activated cell sorting following enrichment and immunofluorescence staining (ALK/cytokeratins/CD45/Hoechst). CNA heterogeneity was evaluated in six ALK-rearranged patients harboring ≥ 10 CTCs/20 mL blood at resistance to 1
st and 3rd ALK-TKIs and one presented gatekeeper mutations. Out of 82 CTCs isolated by FACS, 30 (37%) were ALK+ /cytokeratins- , 46 (56%) ALK- /cytokeratins+ and 4 (5%) ALK+ /cytokeratins+ . Sequencing of 43 CTCs showed highly altered CNA profiles and high levels of chromosomal instability (CIN). Half of CTCs displayed a ploidy >2n and 32% experienced whole-genome doubling. Hierarchical clustering showed significant intra-patient and wide inter-patient CTC diversity. Classification of 121 oncogenic drivers revealed the predominant activation of cell cycle and DNA repair pathways and of RTK/RAS and PI3K to a lower frequency. CTCs showed wide CNA heterogeneity and elevated CIN at resistance to ALK-TKIs. The emergence of epithelial ALK-negative CTCs may drive resistance through activation of bypass signaling pathways, while ALK-rearranged CTCs showed epithelial-to-mesenchymal transition characteristics potentially contributing to ALK-TKI resistance. Comprehensive analysis of CTCs could be of great help to clinicians for precision medicine and resistance to ALK-targeted therapies., (© 2021. The Author(s).)- Published
- 2021
- Full Text
- View/download PDF
29. Isolation of tumor-resident CD8 + T cells from human lung tumors.
- Author
-
Corgnac S, Lecluse Y, and Mami-Chouaib F
- Subjects
- Humans, CD8-Positive T-Lymphocytes immunology, Cell Separation, Lung Neoplasms immunology, Lymphocytes, Tumor-Infiltrating immunology, Memory T Cells immunology, Tumor Microenvironment immunology
- Abstract
CD103
+ CD8+ tumor-resident memory T cells (TRM ) are important components of anti-tumor immunity. However, their role in response to cancer immunotherapy is not fully understood. The protocol describes how to isolate CD8+ T cells and autologous tumor cells from human lung tumors to study the functional activities of CD8+ T cells. Tumors are heterogeneous in terms of the quantity and quality of immune cell types, so the yield of TRM cells depends on the features of the tumor. For complete details on the use and execution of this protocol, please refer to Corgnac et al. (2020)., Competing Interests: The authors declare no competing interests., (© 2020 The Authors.)- Published
- 2021
- Full Text
- View/download PDF
30. Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia.
- Author
-
Laurent AP, Siret A, Ignacimouttou C, Panchal K, Diop M, Jenni S, Tsai YC, Roos-Weil D, Aid Z, Prade N, Lagarde S, Plassard D, Pierron G, Daudigeos E, Lecluse Y, Droin N, Bornhauser BC, Cheung LC, Crispino JD, Gaudry M, Bernard OA, Macintyre E, Barin Bonnigal C, Kotecha RS, Geoerger B, Ballerini P, Bourquin JP, Delabesse E, Mercher T, and Malinge S
- Subjects
- Animals, Computational Biology methods, Disease Models, Animal, Disease Susceptibility, Gene Expression Profiling, Humans, Immunophenotyping, Leukemia, B-Cell therapy, Mice, Mice, Transgenic, Oncogenes, Protein Kinase Inhibitors pharmacology, Pyridones pharmacology, Pyrimidinones pharmacology, Down Syndrome complications, Down Syndrome genetics, Down Syndrome metabolism, Leukemia, B-Cell diagnosis, Leukemia, B-Cell etiology, Mitogen-Activated Protein Kinases metabolism, Signal Transduction drug effects, ras Proteins metabolism
- Abstract
Purpose: Children with Down syndrome (constitutive trisomy 21) that develop acute lymphoblastic leukemia (DS-ALL) have a 3-fold increased likelihood of treatment-related mortality coupled with a higher cumulative incidence of relapse, compared with other children with B-cell acute lymphoblastic leukemia (B-ALL). This highlights the lack of suitable treatment for Down syndrome children with B-ALL., Experimental Design: To facilitate the translation of new therapeutic agents into clinical trials, we built the first preclinical cohort of patient-derived xenograft (PDX) models of DS-ALL, comprehensively characterized at the genetic and transcriptomic levels, and have proven its suitability for preclinical studies by assessing the efficacy of drug combination between the MEK inhibitor trametinib and conventional chemotherapy agents., Results: Whole-exome and RNA-sequencing experiments revealed a high incidence of somatic alterations leading to RAS/MAPK pathway activation in our cohort of DS-ALL, as well as in other pediatric B-ALL presenting somatic gain of the chromosome 21 (B-ALL+21). In murine and human B-cell precursors, activated KRAS
G12D functionally cooperates with trisomy 21 to deregulate transcriptional networks that promote increased proliferation and self renewal, as well as B-cell differentiation blockade. Moreover, we revealed that inhibition of RAS/MAPK pathway activation using the MEK1/2 inhibitor trametinib decreased leukemia burden in several PDX models of B-ALL+21, and enhanced survival of DS-ALL PDX in combination with conventional chemotherapy agents such as vincristine., Conclusions: Altogether, using novel and suitable PDX models, this study indicates that RAS/MAPK pathway inhibition represents a promising strategy to improve the outcome of Down syndrome children with B-cell precursor leukemia., (©2020 American Association for Cancer Research.)- Published
- 2020
- Full Text
- View/download PDF
31. Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice.
- Author
-
Della-Valle V, Roos-Weil D, Scourzic L, Mouly E, Aid Z, Darwiche W, Lecluse Y, Damm F, Mémet S, Mercher T, Aoufouchi S, Nguyen-Khac F, Bernard OA, and Ghamlouch H
- Subjects
- Animals, Leukemia, Lymphocytic, Chronic, B-Cell genetics, Mice, I-kappa B Proteins deficiency, Leukemia, Lymphocytic, Chronic, B-Cell etiology, Proto-Oncogene Proteins deficiency
- Abstract
Aberrant NF-κB activation is a hallmark of most B-cell malignancies. Recurrent inactivating somatic mutations in the NFKBIE gene, which encodes IκBε, an inhibitor of NF-κB-inducible activity, are reported in several B-cell malignancies with highest frequencies in chronic lymphocytic leukemia and primary mediastinal B-cell lymphoma, and account for a fraction of NF-κB pathway activation. The impact of NFKBIE deficiency on B-cell development and function remains, however, largely unknown. Here, we show that Nfkbie-deficient mice exhibit an amplification of marginal zone B cells and an expansion of B1 B-cell subsets. In germinal center (GC)-dependent immune response, Nfkbie deficiency triggers expansion of GC B-cells through increasing cell proliferation in a B-cell autonomous manner. We also show that Nfkbie deficiency results in hyperproliferation of a B1 B-cell subset and leads to increased NF-κB activation in these cells upon Toll-like receptor stimulation. Nfkbie deficiency cooperates with mutant MYD88 signaling and enhances B-cell proliferation in vitro. In aged mice, Nfkbie absence drives the development of an oligoclonal indolent B-cell lymphoproliferative disorders, resembling monoclonal B-cell lymphocytosis. Collectively, these findings shed light on an essential role of IκBε in finely tuning B-cell development and function.
- Published
- 2020
- Full Text
- View/download PDF
32. Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia.
- Author
-
Lopez CK, Noguera E, Stavropoulou V, Robert E, Aid Z, Ballerini P, Bilhou-Nabera C, Lapillonne H, Boudia F, Thirant C, Fagnan A, Arcangeli ML, Kinston SJ, Diop M, Job B, Lecluse Y, Brunet E, Babin L, Villeval JL, Delabesse E, Peters AHFM, Vainchenker W, Gaudry M, Masetti R, Locatelli F, Malinge S, Nerlov C, Droin N, Lobry C, Godin I, Bernard OA, Göttgens B, Petit A, Pflumio F, Schwaller J, and Mercher T
- Subjects
- Adolescent, Age Factors, Animals, Child, Child, Preschool, Female, Humans, Infant, Leukemia, Myeloid, Acute genetics, Mice, Neoplasm Transplantation, Transcription Factors, Tumor Cells, Cultured, Leukemia, Myeloid, Acute pathology, Oncogene Proteins, Fusion genetics
- Abstract
Fusion oncogenes are prevalent in several pediatric cancers, yet little is known about the specific associations between age and phenotype. We observed that fusion oncogenes, such as ETO2-GLIS2 , are associated with acute megakaryoblastic or other myeloid leukemia subtypes in an age-dependent manner. Analysis of a novel inducible transgenic mouse model showed that ETO2-GLIS2 expression in fetal hematopoietic stem cells induced rapid megakaryoblastic leukemia whereas expression in adult bone marrow hematopoietic stem cells resulted in a shift toward myeloid transformation with a strikingly delayed in vivo leukemogenic potential. Chromatin accessibility and single-cell transcriptome analyses indicate ontogeny-dependent intrinsic and ETO2-GLIS2 -induced differences in the activities of key transcription factors, including ERG, SPI1, GATA1, and CEBPA. Importantly, switching off the fusion oncogene restored terminal differentiation of the leukemic blasts. Together, these data show that aggressiveness and phenotypes in pediatric acute myeloid leukemia result from an ontogeny-related differential susceptibility to transformation by fusion oncogenes. SIGNIFICANCE: This work demonstrates that the clinical phenotype of pediatric acute myeloid leukemia is determined by ontogeny-dependent susceptibility for transformation by oncogenic fusion genes. The phenotype is maintained by potentially reversible alteration of key transcription factors, indicating that targeting of the fusions may overcome the differentiation blockage and revert the leukemic state. See related commentary by Cruz Hernandez and Vyas, p. 1653 . This article is highlighted in the In This Issue feature, p. 1631 ., (©2019 American Association for Cancer Research.)
- Published
- 2019
- Full Text
- View/download PDF
33. Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK -Rearranged Non-Small-Cell Lung Cancer.
- Author
-
Pailler E, Faugeroux V, Oulhen M, Mezquita L, Laporte M, Honoré A, Lecluse Y, Queffelec P, NgoCamus M, Nicotra C, Remon J, Lacroix L, Planchard D, Friboulet L, Besse B, and Farace F
- Subjects
- Adult, Aged, Antineoplastic Agents pharmacology, Biomarkers, Tumor, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Non-Small-Cell Lung pathology, Computational Biology methods, Crizotinib pharmacology, Crizotinib therapeutic use, DNA Mutational Analysis, Female, Humans, Immunohistochemistry, Immunophenotyping, Lung Neoplasms drug therapy, Lung Neoplasms pathology, Male, Middle Aged, Mutation, Neoplastic Cells, Circulating pathology, Protein Kinase Inhibitors therapeutic use, Whole Genome Sequencing, Young Adult, Anaplastic Lymphoma Kinase genetics, Carcinoma, Non-Small-Cell Lung genetics, Drug Resistance, Neoplasm genetics, Gene Rearrangement, Lung Neoplasms genetics, Neoplastic Cells, Circulating metabolism, Protein Kinase Inhibitors pharmacology
- Abstract
Purpose: Patients with anaplastic lymphoma kinase ( ALK )-rearranged non-small-cell lung cancer (NSCLC) inevitably develop resistance to ALK inhibitors. New diagnostic strategies are needed to assess resistance mechanisms and provide patients with the most effective therapy. We asked whether single circulating tumor cell (CTC) sequencing can inform on resistance mutations to ALK inhibitors and underlying tumor heterogeneity in ALK -rearranged NSCLC., Experimental Design: Resistance mutations were investigated in CTCs isolated at the single-cell level from patients at disease progression on crizotinib ( n = 14) or lorlatinib ( n = 3). Three strategies including filter laser-capture microdissection, fluorescence activated cell sorting, and the DEPArray were used. One hundred twenty-six CTC pools and 56 single CTCs were isolated and sequenced. Hotspot regions over 48 cancer-related genes and 14 ALK mutations were examined to identify ALK -independent and ALK -dependent resistance mechanisms., Results: Multiple mutations in various genes in ALK-independent pathways were predominantly identified in CTCs of crizotinib-resistant patients. The RTK-KRAS ( EGFR, KRAS, BRAF genes) and TP53 pathways were recurrently mutated. In one lorlatinib-resistant patient, two single CTCs out of 12 harbored ALK compound mutations. CTC-1 harbored the ALK
G1202R/F1174C compound mutation virtually similar to ALKG1202R/F1174L present in the corresponding tumor biopsy. CTC-10 harbored a second ALKG1202R/T1151M compound mutation not detected in the tumor biopsy. By copy-number analysis, CTC-1 and the tumor biopsy had similar profiles, whereas CTC-10 harbored multiple copy-number alterations and whole-genome duplication., Conclusions: Our results highlight the genetic heterogeneity and clinical utility of CTCs to identify therapeutic resistance mutations in ALK -rearranged patients. Single CTC sequencing may be a unique tool to assess heterogeneous resistance mechanisms and help clinicians for treatment personalization and resistance options to ALK-targeted therapies., (©2019 American Association for Cancer Research.)- Published
- 2019
- Full Text
- View/download PDF
34. Agricultural exposures to carbamate herbicides and fungicides and central nervous system tumour incidence in the cohort AGRICAN.
- Author
-
Piel C, Pouchieu C, Carles C, Béziat B, Boulanger M, Bureau M, Busson A, Grüber A, Lecluse Y, Migault L, Renier M, Rondeau V, Schwall X, Tual S, Pierre L, and Baldi I
- Subjects
- Adult, Aged, Agriculture, Animals, Cohort Studies, Crops, Agricultural, Environmental Monitoring, Female, France epidemiology, Humans, Incidence, Male, Middle Aged, Carbamates analysis, Carcinogens analysis, Central Nervous System Neoplasms epidemiology, Fungicides, Industrial analysis, Glioma epidemiology, Herbicides analysis, Meningioma epidemiology, Occupational Exposure analysis
- Abstract
Background: Pesticides exposures could be implicated in the excess of Central Nervous System (CNS) tumors observed in farmers, but evidence concerning individual pesticides remains limited. Carbamate derivative pesticides, including herbicides and fungicides (i.e. (thio/dithio)-carbamates), have shown evidence of carcinogenicity in experimental studies in animals. In the French AGRICAN cohort, we assessed the associations between potential exposures to carbamate herbicides and fungicides and the incidence of CNS tumors, overall and by histological subtype., Methods: AGRICAN enrolled 181,842 participants involved in agriculture. Incident CNS tumors were identified by linkage with cancer registries from enrollment (2005-2007) until 2013. Individual exposures were assessed by combining information on lifetime periods of pesticide use on crops and the French crop-exposure matrix PESTIMAT, for each of the 14 carbamate and thiocarbamate herbicides and the 16 carbamate and dithiocarbamate fungicides registered in France since 1950. Associations were estimated using proportional hazard models with age as the underlying timescale, adjusting for gender, educational level and smoking., Results: During an average follow-up of 6.9 years, 381 incident cases of CNS tumors occurred, including 164 gliomas and 134 meningiomas. Analyses showed increased risks of CNS tumors with overall exposure to carbamate fungicides (Hazard Ratio, HR = 1.88; 95% CI: 1.27-2.79) and, to a lesser extent, to carbamate herbicides (HR = 1.44; 95% CI: 0.94-2.22). Positive associations were observed with specific carbamates, including some fungicides (mancozeb, maneb, metiram) and herbicides (chlorpropham, propham, diallate) already suspected of being carcinogens in humans., Conclusions: Although some associations need to be corroborate in further studies and should be interpreted cautiously, these findings provide additional carcinogenicity evidence for several carbamate fungicides and herbicides., (Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
35. Increased risk of central nervous system tumours with carbamate insecticide use in the prospective cohort AGRICAN.
- Author
-
Piel C, Pouchieu C, Migault L, Béziat B, Boulanger M, Bureau M, Carles C, Grüber A, Lecluse Y, Rondeau V, Schwall X, Tual S, Lebailly P, and Baldi I
- Subjects
- Adult, Aged, Agricultural Workers' Diseases chemically induced, Agricultural Workers' Diseases pathology, Agriculture, Central Nervous System Neoplasms chemically induced, Central Nervous System Neoplasms pathology, Farmers, Female, France epidemiology, Humans, Male, Middle Aged, Occupational Exposure adverse effects, Proportional Hazards Models, Prospective Studies, Agricultural Workers' Diseases epidemiology, Central Nervous System Neoplasms epidemiology, Pesticides toxicity
- Abstract
Background: Pesticide exposures are suspected to be implicated in the excess of central nervous system (CNS) tumours observed in farmers, but evidence concerning individual pesticides remains limited. Carbamate insecticides, used on a wide range of crops, have shown evidence of carcinogenicity in some experimental studies. In the cohort AGRICAN (AGRIculture & CANcer), we assessed the associations between potential exposures to carbamate insecticides and the incidence of CNS tumours, overall and by histological subtype., Methods: AGRICAN enrolled 181 842 participants involved in agriculture. Incident CNS tumours were identified by linkage with cancer registries from enrolment (2005-07) until 2013. Carbamate exposure was assessed by combining information on lifetime periods of pesticide use on crop or livestock and the French crop-exposure matrix PESTIMAT, individually for each of the 19 carbamate insecticides registered in France since 1950. Associations were estimated using proportional hazards models with age as the underlying time scale, adjusting for gender, educational level and smoking., Results: During a 6.9-year average follow-up, 381 incident cases of CNS tumours occurred, including 164 gliomas and 134 meningiomas. Analyses showed increased risks of CNS tumours with overall exposure to carbamate insecticides and linear trends with duration of use of each carbamate. Considering tumour subtypes, hazard ratios for gliomas ranged from 1.18 for thiofanox to 4.60 for formetanate, and for meningiomas from 1.51 for carbaryl to 3.67 for thiofanox., Conclusions: Findings reinforce carcinogenicity evidence for already suspected active ingredients and draw attention to additional active ingredients, notably used on fruit trees, vineyards, potatoes and beets., (© The Author(s) 2018; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.)
- Published
- 2019
- Full Text
- View/download PDF
36. Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy.
- Author
-
Vigneron N, Meryet-Figuière M, Guttin A, Issartel JP, Lambert B, Briand M, Louis MH, Vernon M, Lebailly P, Lecluse Y, Joly F, Krieger S, Lheureux S, Clarisse B, Leconte A, Gauduchon P, Poulain L, and Denoyelle C
- Subjects
- Gene Expression Regulation, Neoplastic, Humans, Neoplasms blood, Neoplasms genetics, Oligonucleotide Array Sequence Analysis, Real-Time Polymerase Chain Reaction, Reference Standards, Gene Expression Profiling methods, Gene Expression Profiling standards, MicroRNAs blood, MicroRNAs genetics
- Abstract
Circulating miRNAs are promising biomarkers in oncology but have not yet been implemented in the clinic given the lack of concordance across studies. In order to increase the cross-studies reliability, we attempted to reduce and to control the circulating miRNA expression variability between patients. First, to maximize profiling signals and to reduce miRNA expression variability, three isolation kits were compared and the NucleoSpin(®) kit provided higher miRNA concentrations than the other widely used kits. Second, to control inter-sample variability during the profiling step, the exogenous miRNAs normalization method commonly used for RT-qPCR validation step was adapted to microarray experiments. Importantly, exogenous miRNAs presented two-fold lower inter-sample variability than the widely used endogenous miR-16-5p reflecting that the latter is subject to both biological and technical variability. Although Caenorhabditis elegans miRNAs isolation yields were heterogeneous, they correlated to each other and to their geometrical mean across samples. The normalization based on the geometrical mean of three exogenous miRNAs increased the correlation up-to 0.97 between the microarrays and individual RT-qPCR steps of circulating miRNAs expression. Overall, this new strategy open new avenue to identify reliable circulating miRNA signatures for translation into clinical practice., (Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
37. Prevalence of monoclonal gammopathy of undetermined significance (MGUS) among farmers involved in open field farming and/or cattle breading in France.
- Author
-
Lecluse Y, Comby E, Mariotte D, Tual S, Le Mauff B, Lebailly P, and Gauduchon P
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Animals, Breeding, Cattle, Female, France epidemiology, Humans, Male, Middle Aged, Multiple Myeloma epidemiology, Prevalence, Young Adult, Agricultural Workers' Diseases epidemiology, Agriculture statistics & numerical data, Farmers statistics & numerical data, Monoclonal Gammopathy of Undetermined Significance epidemiology
- Published
- 2016
- Full Text
- View/download PDF
38. DNA damage in B and T lymphocytes of farmers during one pesticide spraying season.
- Author
-
Lebailly P, Mirey G, Herin F, Lecluse Y, Salles B, and Boutet-Robinet E
- Subjects
- Adult, France, Humans, Longitudinal Studies, Male, Middle Aged, Seasons, B-Lymphocytes drug effects, Crop Production, DNA Damage, Farmers, Occupational Exposure adverse effects, Pesticides toxicity, T-Lymphocytes drug effects
- Abstract
Purpose: The effect of one pesticide spraying season on DNA damage was measured on B and T lymphocytes among open-field farmers and controls., Methods: At least two peripheral blood samples were collected from each individual: one in a period without any pesticide application, several weeks after the last use (January, at period P0), and another in the intensive pesticide spraying period (May or June, at period P4). DNA damage was studied by alkaline comet assay on isolated B or T lymphocytes., Results: Longitudinal comparison of DNA damage observed at both P0 and P4 periods revealed a statistically significant genotoxic effect of the pesticide spraying season in both B (P = 0.02) and T lymphocytes (P = 0.02) in exposed farmers. In contrast, non-farmers did not show any significant modifications. DNA damage levels in B and T lymphocytes were significantly higher in farmers than in non-farmers during the P4 period (P = 0.003 and P = 0.001 for B and T lymphocytes, respectively) but not during the P0 period. The seasonal effect observed among farmers was not correlated with either total farm area, farm area devoted to crops or recent solar exposure. On average, farmers used pesticides for 21 days between P0 and P4. Between the two time points studied, there was a tendency for a potential effect of the number of days of fungicide treatments (r (2) = 0.43; P = 0.11) on T lymphocyte DNA damage., Conclusions: A genotoxic effect was found in lymphocytes of farmers exposed to pesticides, suggesting in particular the possible implication of fungicides.
- Published
- 2015
- Full Text
- View/download PDF
39. The formin DIAPH1 (mDia1) regulates megakaryocyte proplatelet formation by remodeling the actin and microtubule cytoskeletons.
- Author
-
Pan J, Lordier L, Meyran D, Rameau P, Lecluse Y, Kitchen-Goosen S, Badirou I, Mokrani H, Narumiya S, Alberts AS, Vainchenker W, and Chang Y
- Subjects
- Antigens, CD34 metabolism, Blood Platelets cytology, Blood Platelets metabolism, Cell Differentiation, Cloning, Molecular, Formins, GTP Phosphohydrolases metabolism, Humans, Lentivirus genetics, Myosin Type II metabolism, RNA, Small Interfering metabolism, Thrombopoietin chemistry, Tubulin chemistry, Actins metabolism, Adaptor Proteins, Signal Transducing metabolism, Cytoskeleton metabolism, Megakaryocytes cytology, Microtubules metabolism
- Abstract
Megakaryocytes are highly specialized precursor cells that produce platelets via cytoplasmic extensions called proplatelets. Proplatelet formation (PPF) requires profound changes in microtubule and actin organization. In this work, we demonstrated that DIAPH1 (mDia1), a mammalian homolog of Drosophila diaphanous that works as an effector of the small GTPase Rho, negatively regulates PPF by controlling the dynamics of the actin and microtubule cytoskeletons. Moreover, we showed that inhibition of both DIAPH1 and the Rho-associated protein kinase (Rock)/myosin pathway increased PPF via coordination of both cytoskeletons. We provide evidence that 2 major effectors of the Rho GTPase pathway (DIAPH1 and Rock/myosin II) are involved not only in Rho-mediated stress fibers assembly, but also in the regulation of microtubule stability and dynamics during PPF., (© 2014 by The American Society of Hematology.)
- Published
- 2014
- Full Text
- View/download PDF
40. JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.
- Author
-
Besancenot R, Roos-Weil D, Tonetti C, Abdelouahab H, Lacout C, Pasquier F, Willekens C, Rameau P, Lecluse Y, Micol JB, Constantinescu SN, Vainchenker W, Solary E, and Giraudier S
- Subjects
- Animals, Autoantigens genetics, Blood Platelets metabolism, Cell Cycle Checkpoints genetics, Cell Line, Cell Proliferation, Gene Expression, Humans, Iodide Peroxidase genetics, Iron-Binding Proteins genetics, Janus Kinase 2 genetics, Mice, Phenotype, Primary Myelofibrosis genetics, Primary Myelofibrosis metabolism, RNA, Small Interfering genetics, Receptors, Thrombopoietin genetics, Thrombocythemia, Essential genetics, Thrombocythemia, Essential metabolism, Autoantigens metabolism, Cell Differentiation genetics, Iodide Peroxidase metabolism, Iron-Binding Proteins metabolism, Janus Kinase 2 metabolism, Megakaryocytes cytology, Megakaryocytes metabolism, Receptors, Thrombopoietin metabolism
- Abstract
Megakaryopoiesis is a 2-step differentiation process, regulated by thrombopoietin (TPO), on binding to its cognate receptor myeloproliferative leukemia (MPL). This receptor associates with intracytoplasmic tyrosine kinases, essentially janus kinase 2 (JAK2), which regulates MPL stability and cell-surface expression, and mediates TPO-induced signal transduction. We demonstrate that JAK2 and MPL mediate TPO-induced proliferation arrest and megakaryocytic differentiation of the human megakaryoblastic leukemia cell line UT7-MPL. A decrease in JAK2 or MPL protein expression, and JAK2 chemical inhibition, suppress this antiproliferative action of TPO. The expression of JAK2 and MPL, which progressively increases along normal human megakaryopoiesis, is decreased in platelets of patients diagnosed with JAK2- or MPL-mutated essential thrombocytemia and primary myelofibrosis, 2 myeloproliferative neoplasms in which megakaryocytes (MKs) proliferate excessively. Finally, low doses of JAK2 chemical inhibitors are shown to induce a paradoxical increase in MK production, both in vitro and in vivo. We propose that JAK2 and MPL expression levels regulate megakaryocytic proliferation vs differentiation in both normal and pathological conditions, and that JAK2 chemical inhibitors could promote a paradoxical thrombocytosis when used at suboptimal doses., (© 2014 by The American Society of Hematology.)
- Published
- 2014
- Full Text
- View/download PDF
41. Assessment of the genotoxic and carcinogenic potentials of 3-aminothiophene derivatives using in vitro and in silico methodologies.
- Author
-
Lepailleur A, Bureau R, Halm-Lemeille MP, Bouquet M, Pecquet R, Paris-Soubayrol C, Goff JL, André V, Lecluse Y, Lebailly P, Maire MA, and Vasseur P
- Subjects
- Animals, Carcinogenesis drug effects, Cell Transformation, Neoplastic, Cells, Cultured, Comet Assay, Cricetinae, Female, Humans, Middle Aged, Mutagenicity Tests, Salmonella typhimurium drug effects, Carcinogens toxicity, DNA Damage drug effects, Thiophenes toxicity
- Abstract
Thiophene derivatives, a class of compounds widely used in products such as pharmaceuticals, agrochemicals or dyestuffs, represent chemicals of concern. Indeed, the thiophene ring is often considered as a structural moiety that may be involved in toxic effects in humans. We primarily focus on the genotoxic/mutagenic and carcinogenic potentials of the methyl 3-amino-4-methylthiophene-2-carboxylate (1), a precursor of the articaine local anesthetic (4) which falls within the scope of the European REACH (Registration, Evaluation, Authorisation and restriction of CHemicals) legislation. To discern some structure-toxicity relationships, we also studied two related compounds, namely the 3-amino 4-methylthiophene (2) and the 2-acetyl 4-chlorothiophene (3). Techniques employed to assess mutagenic and DNA-damaging effects involved the Salmonella mutagenicity assay (or Ames test) and the single-cell gel electrophoresis assay (or Comet assay). In the range of tested doses, none of these derivatives led to a positive response in the Ames tests and DNA damage was only observed in the Comet assay after high concentration exposure of 2. The study of their carcinogenic potential using the in vitro SHE (Syrian Hamster Embryo) cell transformation assay (CTA) highlighted the activity of compound 2. A combination of experimental data with in silico predictions of the reactivity of thiophene derivatives towards cytochrome P450 (CYP450), enabled us to hypothesize possible pathways leading to these toxicological profiles., (Copyright © 2013 John Wiley & Sons, Ltd.)
- Published
- 2014
- Full Text
- View/download PDF
42. The NF-κB pathway is rarely spontaneously activated in mantle cell lymphoma (MCL) cell lines and patient's samples.
- Author
-
Camara-Clayette V, Lecluse Y, Schrader C, Klapper W, Vainchenker W, Hermine O, and Ribrag V
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers, Tumor metabolism, Cell Growth Processes physiology, Cell Line, Tumor, Cell Survival physiology, Epstein-Barr Virus Infections metabolism, Epstein-Barr Virus Infections pathology, Epstein-Barr Virus Infections virology, Herpesvirus 4, Human isolation & purification, Humans, Immunohistochemistry, Lymphoma, Mantle-Cell pathology, Lymphoma, Mantle-Cell virology, Middle Aged, Lymphoma, Mantle-Cell metabolism, NF-kappa B metabolism
- Abstract
In this study, we investigated the role of NF-κB (canonical and alternative pathways) in the survival or proliferation of mantle cell lymphoma (MCL) cell lines. P50/p65 complexes were detectable by EMSA assays in 4/5 cell lines. Stable expression of a dominant-negative form of IkBa had no effect on proliferation nor on apoptosis in EBV-negative cell lines. Three out of 4 of the cell lines tested exhibited Phospho-p65 (Ser(536)). The alternative NF-κB pathway was not activated in 4/5 cell lines tested. Patient samples were also studied by Western blot, EMSA and Immunohistochemistry (IHC). No p50/p65 complexes were detected in cells freshly collected from 7 patients, but 1/7 cells exhibited Phospho-p65 (Ser(536)). We investigated immunohistochemically, the expression of NF-κB in 86 patients enrolled in two multicentre prospective trials. Patients with MCL exhibiting negative or positive cytoplasmic expression of NF-κB had a median overall survival of 35.7months compared to 22.4months for patients with nuclear NF-κB expression (p=0.0193). All these data suggest that NF-κB does not play a key role in proliferation and apoptotic processes in MCL cell lines. In patient samples, the presence of p65 in the nucleus reflecting NF-κB activation is rare but associated with a poor outcome., (Copyright © 2013 Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
43. Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanisms.
- Author
-
Ali A, Bluteau O, Messaoudi K, Palazzo A, Boukour S, Lordier L, Lecluse Y, Rameau P, Kraus-Berthier L, Jacquet-Bescond A, Lelièvre H, Depil S, Dessen P, Solary E, Raslova H, Vainchenker W, Plo I, and Debili N
- Subjects
- Acetylation, Benzofurans administration & dosage, Cell Growth Processes physiology, DNA Repair, Histone Deacetylase Inhibitors administration & dosage, Humans, Hydroxamic Acids administration & dosage, Phosphorylation, Signal Transduction, Thrombocytopenia genetics, Tumor Suppressor Protein p53 genetics, Benzofurans adverse effects, Histone Deacetylase Inhibitors adverse effects, Hydroxamic Acids adverse effects, Thrombocytopenia chemically induced, Thrombocytopenia metabolism, Tumor Suppressor Protein p53 metabolism
- Abstract
Abexinostat is a pan histone deacetylase inhibitor (HDACi) that demonstrates efficacy in malignancy treatment. Like other HDACi, this drug induces a profound thrombocytopenia whose mechanism is only partially understood. We have analyzed its effect at doses reached in patient plasma on in vitro megakaryopoiesis derived from human CD34(+) cells. When added at day 0 in culture, abexinostat inhibited CFU-MK growth, megakaryocyte (MK) proliferation and differentiation. These effects required only a short incubation period. Decreased proliferation was due to induction of apoptosis and was not related to a defect in TPO/MPL/JAK2/STAT signaling. When added later (day 8), the compound induced a dose-dependent decrease (up to 10-fold) in proplatelet (PPT) formation. Gene profiling from MK revealed a silencing in the expression of DNA repair genes with a marked RAD51 decrease at protein level. DNA double-strand breaks were increased as attested by elevated γH2AX phosphorylation level. Moreover, ATM was phosphorylated leading to p53 stabilization and increased BAX and p21 expression. The use of a p53 shRNA rescued apoptosis, and only partially the defect in PPT formation. These results suggest that HDACi induces a thrombocytopenia by a p53-dependent mechanism along MK differentiation and a p53-dependent and -independent mechanism for PPT formation.
- Published
- 2013
- Full Text
- View/download PDF
44. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.
- Author
-
Thiollier C, Lopez CK, Gerby B, Ignacimouttou C, Poglio S, Duffourd Y, Guégan J, Rivera-Munoz P, Bluteau O, Mabialah V, Diop M, Wen Q, Petit A, Bauchet AL, Reinhardt D, Bornhauser B, Gautheret D, Lecluse Y, Landman-Parker J, Radford I, Vainchenker W, Dastugue N, de Botton S, Dessen P, Bourquin JP, Crispino JD, Ballerini P, Bernard OA, Pflumio F, and Mercher T
- Subjects
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine analogs & derivatives, 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine pharmacology, Aged, Amino Acid Sequence, Animals, Aurora Kinase A, Aurora Kinases, Azepines pharmacology, Base Sequence, Female, Gene Expression Profiling, High-Throughput Nucleotide Sequencing methods, Humans, Infant, Kaplan-Meier Estimate, Kruppel-Like Transcription Factors genetics, Leukemia, Megakaryoblastic, Acute pathology, Male, Mice, Mice, SCID, Middle Aged, Molecular Sequence Data, Oligonucleotide Array Sequence Analysis, Oncogene Proteins, Fusion genetics, Protein Serine-Threonine Kinases antagonists & inhibitors, Pyrimidines pharmacology, Repressor Proteins genetics, Genomics methods, Leukemia, Megakaryoblastic, Acute drug therapy, Leukemia, Megakaryoblastic, Acute genetics, Xenograft Model Antitumor Assays
- Abstract
Acute megakaryoblastic leukemia (AMKL) is a heterogeneous disease generally associated with poor prognosis. Gene expression profiles indicate the existence of distinct molecular subgroups, and several genetic alterations have been characterized in the past years, including the t(1;22)(p13;q13) and the trisomy 21 associated with GATA1 mutations. However, the majority of patients do not present with known mutations, and the limited access to primary patient leukemic cells impedes the efficient development of novel therapeutic strategies. In this study, using a xenotransplantation approach, we have modeled human pediatric AMKL in immunodeficient mice. Analysis of high-throughput RNA sequencing identified recurrent fusion genes defining new molecular subgroups. One subgroup of patients presented with MLL or NUP98 fusion genes leading to up-regulation of the HOX A cluster genes. A novel CBFA2T3-GLIS2 fusion gene resulting from a cryptic inversion of chromosome 16 was identified in another subgroup of 31% of non-Down syndrome AMKL and strongly associated with a gene expression signature of Hedgehog pathway activation. These molecular data provide useful markers for the diagnosis and follow up of patients. Finally, we show that AMKL xenograft models constitute a relevant in vivo preclinical screening platform to validate the efficacy of novel therapies such as Aurora A kinase inhibitors.
- Published
- 2012
- Full Text
- View/download PDF
45. Red cells exchanges in sickle cells disease lead to a selective reduction of erythrocytes-derived blood microparticles.
- Author
-
Mahfoudhi E, Lecluse Y, Driss F, Abbes S, Flaujac C, and Garçon L
- Subjects
- Blood Platelets metabolism, Blood Transfusion, Autologous, Erythrocytes metabolism, Humans, Anemia, Sickle Cell therapy, Cell-Derived Microparticles metabolism, Erythrocyte Transfusion
- Published
- 2012
- Full Text
- View/download PDF
46. Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from Normandy, France.
- Author
-
Turner PC, Hopton RP, Lecluse Y, White KL, Fisher J, and Lebailly P
- Subjects
- Adult, Aged, France, Humans, Male, Middle Aged, Multivariate Analysis, Pilot Projects, Agriculture, Trichothecenes urine
- Abstract
Dietary exposure to deoxynivalenol (DON) from contaminated cereal crops is frequent in Europe, and farm workers who handle grain or silage may be at additional risk. In this study we refined a urinary assay for DON and present a novel assay for the DON metabolite de-epoxy-deoxynivalenol (DOM-1). These were applied to a pilot survey of male French farmers (n = 76, aged 23-74). DON was detected in 75/76 samples (range 0.5-28.8 ng/mL) and DOM-1 in 26/76 samples (range 0.2-2.8 ng/mL). In multivariate analysis including creatinine as a covariate, bread consumption, other cereal consumption, and maize acreage contributed to the model, explaining the variation in urinary "DON and DOM-1" concentration combined (R(2) = 0.33). This is the first exposure biomarker survey for DON in a French population, and the first demonstration of urinary DOM-1 in humans. Further investigations into occupational activity, handling, or airborne exposures would be informative.
- Published
- 2010
- Full Text
- View/download PDF
47. A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis.
- Author
-
Klimchenko O, Mori M, Distefano A, Langlois T, Larbret F, Lecluse Y, Feraud O, Vainchenker W, Norol F, and Debili N
- Subjects
- Animals, Antigens, CD34 metabolism, Cell Differentiation physiology, Cell Lineage physiology, Cells, Cultured, Coculture Techniques, Embryonic Stem Cells metabolism, Glycophorins metabolism, Humans, Leukosialin metabolism, Megakaryocyte-Erythroid Progenitor Cells metabolism, Megakaryocytes metabolism, Mice, Platelet Glycoprotein GPIb-IX Complex metabolism, Platelet Membrane Glycoprotein IIb metabolism, Embryonic Stem Cells physiology, Erythroid Cells cytology, Erythroid Cells metabolism, Hematopoiesis physiology, Megakaryocyte-Erythroid Progenitor Cells physiology, Megakaryocytes physiology
- Abstract
The megakaryocytic (MK) and erythroid lineages are tightly associated during differentiation and are generated from a bipotent megakaryocyte-erythroid progenitor (MEP). In the mouse, a primitive MEP has been demonstrated in the yolk sac. In human, it is not known whether the primitive MK and erythroid lineages are generated from a common progenitor or independently. Using hematopoietic differentiation of human embryonic stem cells on the OP9 cell line, we identified a primitive MEP in a subset of cells coexpressing glycophorin A (GPA) and CD41 from day 9 to day 12 of coculturing. This MEP differentiates into primitive erythroid (GPA(+)CD41(-)) and MK (GPA(-)CD41(+)) lineages. In contrast to erythropoietin (EPO)-dependent definitive hematopoiesis, KIT was not detected during erythroid differentiation. A molecular signature for the commitment and differentiation toward both the erythroid and MK lineages was detected by assessing expression of transcription factors, thrombopoietin receptor (MPL) and erythropoietin receptor (EPOR). We showed an inverse correlation between FLI1 and both KLF1 and EPOR during primitive erythroid and MK differentiation, similar to definitive hematopoiesis. This novel MEP differentiation system may allow an in-depth exploration of the molecular bases of erythroid and MK commitment and differentiation.
- Published
- 2009
- Full Text
- View/download PDF
48. Agricultural pesticide exposure and the molecular connection to lymphomagenesis.
- Author
-
Agopian J, Navarro JM, Gac AC, Lecluse Y, Briand M, Grenot P, Gauduchon P, Ruminy P, Lebailly P, Nadel B, and Roulland S
- Subjects
- Adult, B-Lymphocyte Subsets physiology, Base Sequence, Genetic Predisposition to Disease, Genotype, Humans, Male, Middle Aged, Molecular Sequence Data, Phenotype, Proto-Oncogene Proteins c-bcl-2 genetics, Proto-Oncogene Proteins c-bcl-2 metabolism, Agricultural Workers' Diseases chemically induced, Agricultural Workers' Diseases genetics, Chromosomes, Human, Pair 14 genetics, Chromosomes, Human, Pair 18 genetics, Lymphoma, Follicular chemically induced, Lymphoma, Follicular genetics, Occupational Exposure, Pesticides adverse effects, Translocation, Genetic
- Abstract
The t(14;18) translocation constitutes the initiating event of a causative cascade leading to follicular lymphoma (FL). t(14;18) translocations are present in blood from healthy individuals, but there is a trend of increased prevalence in farmers exposed to pesticides, a group recently associated with higher risk of t(14;18)(+) non-Hodgkin's lymphoma development. A direct connection between agricultural pesticide use, t(14;18) in blood, and malignant progression, however, has not yet been demonstrated. We followed t(14;18) clonal evolution over 9 yr in a cohort of farmers exposed to pesticides. We show that exposed individuals bear particularly high t(14;18) frequencies in blood because of a dramatic clonal expansion of activated t(14;18)(+) B cells. We further demonstrate that such t(14;18)(+) clones recapitulate the hallmark features of developmentally blocked FL cells, with some displaying aberrant activation-induced cytidine deaminase activity linked to malignant progression. Collectively, our data establish that expanded t(14;18)(+) clones constitute bona fide precursors at various stages of FL development, and provide a molecular connection between agricultural pesticide exposure, t(14;18) frequency in blood, and clonal progression.
- Published
- 2009
- Full Text
- View/download PDF
49. t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals.
- Author
-
Lecluse Y, Lebailly P, Roulland S, Gac AC, Nadel B, and Gauduchon P
- Subjects
- Adult, Blood Cells, Cell Transformation, Neoplastic, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 14, Humans, Male, Middle Aged, Clone Cells cytology, Translocation, Genetic
- Published
- 2009
- Full Text
- View/download PDF
50. The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis.
- Author
-
Noman MZ, Buart S, Van Pelt J, Richon C, Hasmim M, Leleu N, Suchorska WM, Jalil A, Lecluse Y, El Hage F, Giuliani M, Pichon C, Azzarone B, Mazure N, Romero P, Mami-Chouaib F, and Chouaib S
- Subjects
- Cell Line, Tumor, Clone Cells, Gene Expression Regulation, Neoplastic immunology, Humans, Hypoxia metabolism, Hypoxia pathology, Hypoxia-Inducible Factor 1, alpha Subunit physiology, Immunity, Innate, Lung Neoplasms metabolism, Lung Neoplasms pathology, STAT3 Transcription Factor antagonists & inhibitors, STAT3 Transcription Factor genetics, STAT3 Transcription Factor physiology, T-Lymphocytes, Cytotoxic metabolism, T-Lymphocytes, Cytotoxic pathology, Cytotoxicity, Immunologic, Hypoxia immunology, Hypoxia-Inducible Factor 1, alpha Subunit biosynthesis, Lung Neoplasms immunology, STAT3 Transcription Factor biosynthesis, T-Lymphocytes, Cytotoxic immunology
- Abstract
Hypoxia is an essential component of tumor microenvironment. In this study, we investigated the influence of hypoxia (1% PO(2)) on CTL-mediated tumor cell lysis. We demonstrate that exposure of target tumor cells to hypoxia has an inhibitory effect on the CTL clone (Heu171)-induced autologous target cell lysis. Such inhibition correlates with hypoxia-inducible factor-1alpha (HIF-1alpha) induction but is not associated with an alteration of CTL reactivity as revealed by granzyme B polarization or morphological change. Western blot analysis indicates that although hypoxia had no effect on p53 accumulation, it induced the phosphorylation of STAT3 in tumor cells by a mechanism at least in part involving vascular endothelial growth factor secretion. We additionally show that a simultaneous nuclear translocation of HIF-1alpha and phospho-STAT3 was observed. Interestingly, gene silencing of STAT3 by small interfering RNA resulted in HIF-1alpha inhibition and a significant restoration of target cell susceptibility to CTL-induced killing under hypoxic conditions by a mechanism involving at least in part down-regulation of AKT phosphorylation. Moreover, knockdown of HIF-1alpha resulted in the restoration of target cell lysis under hypoxic conditions. This was further supported by DNA microarray analysis where STAT3 inhibition resulted in a partly reversal of the hypoxia-induced gene expression profile. The present study demonstrates that the concomitant hypoxic induction of phospho-STAT3 and HIF-1alpha are functionally linked to the alteration of non-small cell lung carcinoma target susceptibility to CTL-mediated killing. Considering the eminent functions of STAT3 and HIF-1alpha in the tumor microenvironment, their targeting may represent novel strategies for immunotherapeutic intervention.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.